Other infectious diseases

AB1_OTHER_INFECTIONS

infectious disease: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B99 Hospital discharge: ICD-9 — 136[8-9] Hospital discharge: ICD-8 — 1360[8-9] Cause of death: ICD-10 — B99 Cause of death: ICD-9 — 136[8-9] Cause of death: ICD-8 — 1360[8-9] 2 out of 7 registries used, show all original rules.	3137
4. Check minimum number of events None	3137
5. Include endpoints None	3137
6. Filter based on genotype QC (FinnGen only)	3137

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: B99-B99
Name in latin: Morbi infectiosi alii et non specificati

NAME	AB1_OTHER_INFECTIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B99
HD_ICD_9	136[8-9]
HD_ICD_8	1360[8-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B99
COD_ICD_9	136[8-9]
COD_ICD_8	1360[8-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other infectious diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30118	14298	15550
Only index persons	25362	12247	13115
Unadjusted period prevalence (%)
Whole population	0.42	0.41	0.43
Only index persons	0.48	0.45	0.50
Median age at first event (years)
Whole population	65.84	66.85	64.81
Only index persons	64.46	65.47	63.51

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3137	1510	1627
Unadjusted period prevalence (%)	0.62	0.51	0.72
Median age at first event (years)	61.32	56.29	66.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2877: Matched controls
28770

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B99

ICD-10 Finland

Other and unspecified infectious diseases

10658.5

323.0

2708

R50.9

ICD-10 Finland

Fever, unspecified

6.3

317.4

997

2218

A49.9

ICD-10 Finland

Bacterial infection, unspecified

6.8

302.9

878

1739

J01MA12

ATC

levofloxacin; systemic

3.6

157.6

900

3266

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.1

146.4

1114

4933

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.6

128.5

1546

8859

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

105.2

607

2127

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.2

98.6

600

2175

13609

ICD-8 Finland

Other and unspecified infective and parasitic diseases, Morbus infectiosus sive parasitarius NUD

+∞

97.4

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

95.5

819

3703

J01MA14

ATC

moxifloxacin; systemic

3.8

90.9

434

1295

C03CA01

ATC

furosemide; systemic

2.3

90.5

1151

6389

A41.9

ICD-10 Finland

Sepsis, unspecified

5.9

88.4

262

478

J01MA02

ATC

ciprofloxacin; systemic

2.1

76.2

1300

8062

J01DB01

ATC

cefalexin; oral

2.3

72.0

2362

19087

JN4BD

NOMESCO Finland

Extensive body CT

3.0

68.9

447

1656

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

66.7

599

2701

ZX120

NOMESCO Finland

Intravenous

3.1

66.5

404

1428

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.3

66.3

166

240

H02AB06

ATC

prednisolone; systemic

2.0

65.7

1424

9527

N02AA05

ATC

oxycodone; systemic

2.6

65.0

565

2496

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

62.9

1013

5991

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.0

62.4

406

1501

127

Kela drug reimbursment

Transplant complication

10.7

61.8

122

118

A02BC02

ATC

pantoprazole; systemic

1.9

61.5

1869

14033

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.7

60.2

218

495

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

60.0

364

1281

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

58.2

567

2647

L04AA06

ATC

mycophenolic acid; systemic

9.1

57.8

125

143

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.2

57.2

161

273

TK800

NOMESCO Finland

Hemodialysis

6.8

57.1

149

228

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

56.0

904

5297

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

55.4

594

2902

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.5

54.7

276

845

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.8

54.2

190

417

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.3

53.7

294

958

A46

ICD-10 Finland

Erysipelas

2.4

52.3

513

2389

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

52.2

594

2977

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.6

52.1

159

298

N02AX02

ATC

tramadol; systemic, rectal

1.8

51.4

1260

8538

B03XA02

ATC

darbepoetin alfa; parenteral

7.0

51.0

131

196

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

10.3

50.8

102

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

50.6

257

790

M04AA01

ATC

allopurinol; systemic

2.3

50.4

514

2438

A11CC03

ATC

alfacalcidol; systemic

5.9

50.4

146

257

N02BE01

ATC

paracetamol; systemic, rectal

2.1

49.8

2419

20615

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.5

49.7

154

294

Z49.1

ICD-10 Finland

Extracorporeal dialysis

8.6

48.2

107

128

1369X

ICD-9 Finland

Other and unspecified infectious and parasitic diseases, Unspecified infectious and parasitic diseases

+∞

48.0

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.8

47.8

1398

9959

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

46.7

1014

6526

XW000

NOMESCO Finland

Bone marrow biopsy

4.1

45.9

188

480

A41.8

ICD-10 Finland

Other specified sepsis

7.8

45.5

108

144

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.5

45.4

168

389

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

45.4

597

3166

J01FF01

ATC

clindamycin; systemic

1.9

45.3

816

4905

L04AX01

ATC

azathioprine; systemic

4.0

44.8

190

501

R53

ICD-10 Finland

Malaise and fatigue

2.0

43.4

678

3852

N18.8

ICD-10 Finland

Other chronic renal failure

4.8

42.5

148

322

L04AD01

ATC

ciclosporin; systemic

6.9

42.4

109

164

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

42.1

558

2960

N18.0

ICD-10 Finland

End-stage renal disease

8.0

41.5

123

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

41.5

315

1263

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.8

40.9

142

308

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

40.7

516

2681

WW500

NOMESCO Finland

Blood transfusion

3.9

40.6

176

473

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

40.6

481

2424

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

40.4

367

1627

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

3.7

38.8

181

518

Z94.0

ICD-10 Finland

Kidney transplant status

9.0

38.2

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.2

38.1

218

729

B01AA03

ATC

warfarin; systemic

1.9

37.8

704

4234

A03

ICPC

Fever

2.2

37.7

449

2262

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

37.5

759

4694

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.3

37.3

118

231

A12AA04

ATC

calcium carbonate; oral

6.1

37.3

104

175

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

37.1

366

1688

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

36.9

522

2829

UJF32

NOMESCO Finland

Coloscopy

1.8

36.5

749

4645

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

36.0

612

3549

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.2

35.7

201

663

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.8

35.0

108

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.5

33.7

278

1164

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

33.7

417

2130

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

33.2

281

1194

N03AX16

ATC

pregabalin; oral

1.8

33.2

660

4031

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

33.0

325

1493

R4110

NOMESCO Finland

Physiotherapy

1.8

32.8

749

4784

A07AA09

ATC

vancomycin; oral

7.5

32.6

106

L04AA01

ATC

[U] ciclosporin; systemic

6.2

32.4

147

B01AB05

ATC

enoxaparin; parenteral

1.7

32.4

857

5721

D70.82

ICD-10 Finland

Drug-induced neutropenia

5.8

32.3

167

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.3

31.9

165

513

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

10.0

31.8

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

31.7

219

827

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.5

31.6

262

1099

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.4

31.3

292

1305

C07AB07

ATC

bisoprolol; oral

1.6

31.1

1351

10276

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.1

31.1

178

595

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.7

30.8

B34.9

ICD-10 Finland

Viral infection, unspecified

4.4

30.4

113

264

13608

ICD-8 Finland

Other and unspecified infective and parasitic diseases

+∞

30.3

L03AA02

ATC

filgrastim; parenteral

4.3

30.2

115

275

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

29.7

864

5894

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

29.2

332

1627

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

28.9

245

1038

Z50.1

ICD-10 Finland

Other physical therapy

2.8

28.8

198

744

L28

ICPC

Limited function/disability (L)

1.9

28.8

492

2835

A04AA01

ATC

ondansetron; systemic, rectal

2.7

28.7

205

789

H02AB02

ATC

dexamethasone; systemic

2.2

28.5

309

1480

A10AE04

ATC

insulin glargine; parenteral

2.2

28.3

313

1515

A06AD11

ATC

lactulose; oral

1.9

28.0

475

2729

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

27.8

181

660

137

Kela drug reimbursment

Uraemia requiring dialysis

8.8

27.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

27.4

511

3033

H02AB07

ATC

prednisone; oral

1.9

27.1

430

2409

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

26.9

686

4483

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.1

26.6

325

1641

A07AA02

ATC

nystatin; oral

2.6

26.6

210

858

R11

ICD-10 Finland

Nausea and vomiting

2.3

26.4

254

1149

D70.89

ICD-10 Finland

Neutropenic splenomegaly

6.8

26.2

101

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

9.2

26.2

AA1AD

NOMESCO Finland

CT of head and brain

1.7

25.9

680

4474

A98.5

ICD-10 Finland

Haemorrhagic fever with renal syndrome

5.0

25.8

171

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.1

25.6

143

470

A02BC01

ATC

omeprazole; systemic

1.6

25.6

780

5343

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.2

25.5

237

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.6

25.5

193

769

196

Kela drug reimbursment

Paricalcitol and cinacalcet

12.7

25.3

V03AE01

ATC

polystyrene sulfonate; oral

5.7

25.2

130

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

15.4

25.0

A28

ICPC

Limited function/disability NOS

1.8

24.9

458

2696

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

24.9

310

1576

P01AB01

ATC

metronidazole; oral, rectal

1.6

24.8

997

7314

A04AA02

ATC

granisetron; systemic, transdermal

2.6

24.7

195

796

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

24.5

236

1068

N05CF01

ATC

zopiclone; oral

1.6

24.5

907

6520

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

23.7

231

1051

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.0

23.7

141

484

R06.0

ICD-10 Finland

Dyspnoea

1.6

23.6

681

4580

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

23.6

526

3288

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

23.6

725

4960

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

23.6

325

1720

Z49.0

ICD-10 Finland

Preparatory care for dialysis

7.0

23.4

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

22.9

213

947

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

8.7

22.8

J01CA04

ATC

amoxicillin; systemic

1.5

22.7

2111

18480

S97

ICPC

Chronic ulcer skin

2.5

22.6

185

769

M10.9

ICD-10 Finland

Gout, unspecified

2.3

22.5

223

1021

V03AE02

ATC

sevelamer; oral

11.2

22.4

WW200

NOMESCO Finland

Immunization

3.5

22.0

107

318

A10AE05

ATC

insulin detemir; parenteral

2.4

22.0

187

795

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

21.7

477

2961

NHQ40

NOMESCO Finland

Amputation of toe

4.3

21.6

192

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

21.6

750

5273

B03XA01

ATC

erythropoietin; parenteral

6.7

21.5

SPAT1255

SPAT

Intravenous administration of medicine

2.3

21.5

203

909

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.4

21.5

108

330

J01FA06

ATC

roxithromycin; oral

1.5

21.4

1043

7917

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

21.4

306

1641

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

21.2

1009

7620

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

21.1

258

1300

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

9.1

21.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

20.7

142

534

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.8

20.6

146

H05BX01

ATC

cinacalcet; oral

8.7

20.6

Z99.2

ICD-10 Finland

Dependence on renal dialysis

110.8

20.6

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

7.9

20.2

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

12.1

20.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

20.0

303

1661

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.1

19.9

198

TGC00

NOMESCO Finland

Bronchial lavation

3.6

19.7

261

N06AX11

ATC

mirtazapine; oral

1.5

19.6

794

5762

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

19.5

816

5964

C08CA01

ATC

amlodipine; oral

1.5

19.5

946

7141

SPAT1254

SPAT

Administration of medicine

1.7

19.4

419

2581

J01AA02

ATC

doxycycline; systemic

1.5

19.4

2038

17913

H02AB04

ATC

methylprednisolone; systemic

1.8

19.4

396

2399

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.3

19.4

187

848

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

19.3

292

1599

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

19.2

215

1041

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.7

19.0

227

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

18.9

197

926

ZX108

NOMESCO Finland

Inhalation

7.8

18.8

JN4AD

NOMESCO Finland

Body CT examination

2.1

18.8

223

1109

UKC02

NOMESCO Finland

Cystoscopy

1.7

18.5

472

3044

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

3.7

18.5

232

Z49.2

ICD-10 Finland

Other dialysis

7.5

18.4

I50.0

ICD-10 Finland

Congestive heart failure

2.0

18.3

257

1368

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

18.3

1156

9169

R31

ICD-10 Finland

Unspecified haematuria

1.9

18.3

302

1705

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.4

18.2

272

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

18.2

212

1044

N05AH04

ATC

quetiapine; oral

1.7

18.2

410

2555

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

7.6

18.1

N06AB04

ATC

citalopram; systemic

1.6

18.1

540

3634

N05BA04

ATC

oxazepam; oral

1.5

18.0

635

4446

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

17.9

678

4828

C03DA01

ATC

spironolactone; oral

1.8

17.9

315

1814

N19

ICD-10 Finland

Unspecified kidney failure

2.8

17.9

120

448

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

17.8

199

965

WX002

NOMESCO Finland

Sedation and analgesia

1.6

17.8

509

3386

J02AC01

ATC

fluconazole; systemic

1.5

17.8

906

6875

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

17.8

129

502

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

17.8

241

1265

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

17.8

544

3681

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

17.7

495

3270

H02AB09

ATC

hydrocortisone; systemic

3.6

17.7

231

JN4CD

NOMESCO Finland

Very extensive body CT

2.6

17.6

129

507

A12BA01

ATC

potassium chloride; oral

2.3

17.5

169

766

B05DA

ATC

Isotonic solutions

7.4

17.4

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.9

17.3

185

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.5

17.0

135

A02BC05

ATC

esomeprazole; systemic

1.4

17.0

998

7773

A05AA02

ATC

ursodeoxycholic acid; oral

4.3

16.9

145

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

16.9

146

625

C07AB02

ATC

metoprolol; systemic

1.5

16.9

597

4175

ZX112

NOMESCO Finland

Subcutaneous

3.5

16.9

224

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.6

16.9

125

494

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

16.9

332

1985

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

19.4

16.9

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

16.9

213

1085

WX892

NOMESCO Finland

Monitored bed care

2.0

16.8

219

1133

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.9

16.7

111

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

16.7

122

477

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

16.7

382

2389

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

15.1

16.6

R60.0

ICD-10 Finland

Localized oedema

1.8

16.4

290

1675

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.1

16.3

194

963

P01BA02

ATC

hydroxychloroquine; oral

2.1

16.2

200

1008

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.4

16.2

A40.8

ICD-10 Finland

Other streptococcal sepsis

6.2

16.2

E0000UV

ATC

1.4

16.1

955

7435

3AC01

NOMESCO Finland

5.2

16.0

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

16.0

213

1108

B05DB

ATC

Hypertonic solutions

7.3

16.0

N05BA01

ATC

diazepam; systemic, rectal

1.7

16.0

355

2199

Z94.1

ICD-10 Finland

Heart transplant status

21.1

16.0

205

Kela drug reimbursment

Chronic hypertension

1.5

16.0

800

6025

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

15.9

545

3779

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.7

15.8

K65.0

ICD-10 Finland

Acute peritonitis

4.7

15.8

114

ZXA00

NOMESCO Finland

Right side

1.5

15.8

699

5129

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

15.8

182

896

SPAT1263

SPAT

Sampling

1.4

15.7

1063

8466

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.6

15.7

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

15.4

213

1126

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

15.4

147

661

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

15.4

125

520

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

15.4

130

551

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

15.3

228

1238

J05AB11

ATC

valaciclovir; oral

1.7

15.2

318

1934

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.9

15.1

313

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.2

15.0

155

725

E000001

ATC

1.5

15.0

517

3582

A04

ICPC

Weakness/tiredness general

1.7

15.0

341

2124

SPAT1262

SPAT

Handing over of treatment supplies

1.6

15.0

475

3228

WX110

NOMESCO Finland

Local anesthesy

1.4

14.8

1661

14364

R81

ICPC

Pneumonia

2.8

14.8

352

R42

ICD-10 Finland

Dizziness and giddiness

1.5

14.8

556

3932

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.3

14.7

132

579

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

14.7

157

746

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

14.6

675

4989

N30.0

ICD-10 Finland

Acute cystitis

1.7

14.5

341

2141

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

14.5

220

A29

ICPC

General symptom/complaint other

1.7

14.5

286

1708

R03BB04

ATC

tiotropium bromide; inhalant

1.8

14.5

282

1678

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.5

14.4

118

492

L03AA13

ATC

pegfilgrastim; parenteral

2.6

14.4

106

420

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.2

14.3

234

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

14.3

440

2970

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

14.2

225

1250

E86

ICD-10 Finland

Volume depletion

2.9

14.2

313

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

14.2

445

3013

K92.1

ICD-10 Finland

Melaena

2.1

14.2

159

773

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.6

14.2

182

RD210

NOMESCO Finland

3.7

14.2

172

N06AX16

ATC

venlafaxine; oral

1.7

14.1

302

1846

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

14.1

383

2502

N05CF02

ATC

zolpidem; oral

1.6

14.1

408

2711

V03AE03

ATC

lanthanum carbonate; oral

12.0

14.1

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

14.0

103

406

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

14.0

278

1664

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.2

13.9

147

695

L88

ICPC

Rheumatoid/seropositive arthritis

2.6

13.8

101

395

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

17.6

13.8

C01AA05

ATC

digoxin; systemic

1.8

13.7

265

1571

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

13.7

196

1050

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

13.6

13.7

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.9

13.7

297

ZZA00

NOMESCO Finland

Split skin graft

2.7

13.6

360

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

13.5

110

460

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

13.5

134

RS221

NOMESCO Finland

4.2

13.5

120

N03AX12

ATC

gabapentin; oral

1.6

13.4

365

2383

QDA10

NOMESCO Finland

Incision of skin of lower limb

6.8

13.4

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.4

13.4

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

12.9

13.4

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

13.3

105

431

E87.5

ICD-10 Finland

Hyperkalaemia

3.6

13.3

171

AN1

Coronary angiography

1.6

13.3

335

2146

K83.0

ICD-10 Finland

Cholangitis

3.7

13.3

161

J01MA06

ATC

norfloxacin; oral

1.6

13.2

339

2181

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

40.2

13.1

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.9

13.1

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

13.1

155

771

H26.3

ICD-10 Finland

Drug-induced cataract

7.9

13.1

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.6

13.1

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

5.0

13.0

J01EA01

ATC

trimethoprim; systemic

1.4

13.0

624

4631

C08CA02

ATC

felodipine; oral

1.7

13.0

261

1566

J01CF02

ATC

cloxacillin; systemic

2.8

12.9

298

I50.1

ICD-10 Finland

Left ventricular failure

2.1

12.9

152

756

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

12.9

105

437

M05BA04

ATC

alendronic acid; oral

1.8

12.9

219

1249

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.4

12.8

187

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

12.8

626

4658

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

12.8

178

943

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

4.9

12.8

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

12.8

116

511

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

12.8

215

PAW37

NOMESCO Finland

Biopsy of temporal artery

5.1

12.7

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.7

12.6

314

L04AA13

ATC

leflunomide; oral

3.0

12.6

243

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

11.0

12.5

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

12.5

106

453

R07.3

ICD-10 Finland

Other chest pain

1.8

12.5

235

1385

Q61.3

ICD-10 Finland

Polycystic kidney, unspecified

9.3

12.5

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.5

12.4

160

B01AB10

ATC

tinzaparin; parenteral

1.9

12.4

175

934

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

2.5

12.4

380

TK810

NOMESCO Finland

Hemofiltration

6.9

12.4

R51.80

ICD-10 Finland

Headache

1.6

12.3

333

2172

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

5.7

12.2

R33

ICD-10 Finland

Retention of urine

1.8

12.2

227

1330

XPX08

NOMESCO Finland

Intraoperative flow measurement

4.4

12.2

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

12.2

245

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

12.1

139

681

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

12.1

459

3240

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

12.1

295

1871

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.5

12.1

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.3

12.1

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

12.1

112

501

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.7

12.0

144

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.8

12.0

134

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

12.0

145

730

A07EC01

ATC

sulfasalazine; oral, rectal

1.8

12.0

198

1115

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

12.0

361

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

11.9

163

858

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

11.8

118

546

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.9

11.8

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.4

11.7

163

N06AA09

ATC

amitriptyline; systemic

1.7

11.7

238

1436

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.6

11.7

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.3

11.6

107

478

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.3

11.6

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.7

11.6

R55

ICD-10 Finland

Syncope and collapse

1.6

11.6

287

1826

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.7

11.6

288

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.3

11.6

106

471

B96.5

ICD-10 Finland

Pseudomonas (aeruginosa) as the cause of diseases classified to other chapters

120.4

11.4

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

7.5

11.4

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

7.5

11.4

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

4.2

11.4

101

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

11.4

171

934

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

11.4

169

919

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.1

11.3

133

659

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

11.8

11.3

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.3

11.3

107

485

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

11.3

260

1623

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

11.2

577

4322

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

4.1

11.2

103

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.3

11.2

103

459

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.3

11.2

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

11.2

214

1265

J96.0

ICD-10 Finland

Acute respiratory failure

3.4

11.1

159

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

11.1

417

2933

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

11.1

1467

12742

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.5

11.1

353

RS220

NOMESCO Finland

3.5

11.1

144

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.1

11.1

125

613

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.2

11.0

107

487

TAB00

NOMESCO Finland

Lumbar puncture

2.2

11.0

107

487

5BA08

NOMESCO Finland

6.1

11.0

L01AA01

ATC

cyclophosphamide; systemic

7.1

11.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

11.0

256

Z94.4

ICD-10 Finland

Liver transplant status

10.1

11.0

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

11.0

342

2308

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

11.0

173

959

K92.0

ICD-10 Finland

Haematemesis

2.6

11.0

298

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.0

10.9

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.2

10.9

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

10.9

173

964

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

10.9

161

873

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

10.9

196

1136

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

10.9

268

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.9

10.9

111

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

10.8

127

630

C01DA14

ATC

isosorbide mononitrate; oral

1.5

10.8

460

3323

R05FB02

ATC

cough suppressants and expectorants

1.3

10.7

934

7628

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.6

10.7

288

N05CD07

ATC

temazepam; oral

1.5

10.7

339

2294

A10BA02

ATC

metformin; oral

1.4

10.7

697

5437

E000006

ATC

1.8

10.7

173

969

N05AX08

ATC

risperidone; systemic

1.7

10.7

212

1267

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

28.1

10.7

Z51.5

ICD-10 Finland

Palliative care

1.9

10.7

167

923

SPAT1336

SPAT

Request for examination

2.2

10.7

103

472

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

10.6

133

680

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.5

10.6

335

NFQ20

NOMESCO Finland

Amputation of femur

4.1

10.6

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

10.6

141

739

R05

ICPC

Cough

1.4

10.5

492

3615

H3603, E103

ICD-10 Finland

4.5

10.5

N05AH03

ATC

olanzapine; systemic

2.0

10.5

136

704

R52.0

ICD-10 Finland

Acute pain

2.4

10.5

357

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

10.5

277

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

10.5

173

978

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

10.5

377

2628

ZXA05

NOMESCO Finland

Left side

1.4

10.4

637

4912

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

10.4

484

3553

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

5.4

10.4

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

7.7

10.4

C02AC05

ATC

moxonidine; oral

2.1

10.3

120

596

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.2

10.3

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

10.3

148

796

N06AX21

ATC

duloxetine; oral

1.7

10.2

224

1381

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.7

10.2

118

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

10.1

345

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.5

10.1

300

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.6

10.1

124

N03AX09

ATC

lamotrigine; oral

2.2

10.1

437

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

10.1

337

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

11.3

10.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.0

163

914

212

Kela drug reimbursment

Gout

2.6

10.0

277

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.3

10.0

146

J05AB01

ATC

aciclovir; systemic

1.4

10.0

482

3560

X58

ICD-10 Finland

Exposure to other specified factors

1.6

10.0

300

2005

SPAT1301

SPAT

No procedures

1.3

10.0

773

6192

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

9.9

159

889

A01AB09

ATC

miconazole; local oral

1.7

9.9

213

1307

A01

ICPC

Pain general/multiple sites

1.7

9.9

184

1081

C08CA05

ATC

nifedipine; systemic

1.8

9.8

180

1052

N06AB10

ATC

escitalopram; oral

1.5

9.8

417

3003

R50.8

ICD-10 Finland

Other specified fever

6.3

9.8

SPAT1229

SPAT

Assessment of need for aid

1.7

9.8

207

1264

A48.8

ICD-10 Finland

Other specified bacterial diseases

10.6

9.8

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

9.7

623

4834

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

9.7

229

1441

A02BC03

ATC

lansoprazole; oral

1.3

9.6

703

5575

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.4

9.6

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.6

9.6

272

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

9.6

272

1794

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

9.6

429

E66.8

ICD-10 Finland

Other obesity

2.1

9.5

111

550

NGQ20

NOMESCO Finland

Amputation of lower leg

5.0

9.5

J01DA01

ATC

[U] cefalexin; systemic

1.3

9.5

1570

13922

A10BB12

ATC

glimepiride; oral

1.7

9.5

206

1266

R13

ICD-10 Finland

Dysphagia

1.8

9.5

155

871

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.7

9.5

M05BX04

ATC

denosumab; parenteral

2.0

9.5

115

580

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.6

9.5

257

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

9.4

117

596

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.6

9.4

A10BH05

ATC

linagliptin; oral

1.9

9.4

129

681

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

17.6

9.4

C02CA01

ATC

prazosin; oral

2.8

9.4

214

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

9.4

205

G72.8

ICD-10 Finland

Other specified myopathies

3.1

9.3

160

J01CA08

ATC

pivmecillinam; oral

1.3

9.3

850

6958

F05.9

ICD-10 Finland

Delirium, unspecified

2.7

9.3

230

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

9.3

568

4375

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

9.3

102

494

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

9.2

470

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

9.2

285

C07AG02

ATC

carvedilol; oral

1.8

9.2

160

919

WX730

NOMESCO Finland

Conventional respirator

2.9

9.2

189

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

7.3

9.2

SPAT1138

SPAT

Guidance concerning bowel function

3.1

9.2

156

C09AA05

ATC

ramipril; oral

1.4

9.2

634

4975

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

9.2

191

1162

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

9.1

177

1052

K81.0

ICD-10 Finland

Acute cholecystitis

2.6

9.1

244

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.9

9.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

9.1

185

1116

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

9.1

198

1218

L01BB05

ATC

fludarabine; systemic

15.6

9.0

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

9.0

146

822

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.8

9.0

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

9.0

271

1812

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.7

8.9

217

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

8.9

166

975

Z94.2

ICD-10 Finland

Lung transplant status

24.1

8.9

M79.6

ICD-10 Finland

Pain in limb

1.3

8.9

811

6632

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.2

8.8

144

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.8

8.8

C09AA02

ATC

enalapril; systemic

1.4

8.8

505

3843

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.1

8.8

487

B01AB04

ATC

dalteparin; parenteral

1.9

8.8

128

693

M10.3

ICD-10 Finland

Gout due to impairment of renal function

6.3

8.8

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.6

8.8

238

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

3.4

8.8

118

J01XX08

ATC

linezolid; systemic

5.1

8.8

JAH01

NOMESCO Finland

Laparoscopy

2.1

8.7

465

WZC30

NOMESCO Finland

Teaching

1.5

8.7

297

2042

N03AF02

ATC

oxcarbazepine; oral

2.2

8.7

374

H05BX02

ATC

paricalcitol; systemic

14.1

8.7

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.8

8.7

202

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

8.7

127

689

C90.0

ICD-10 Finland

Multiple myeloma

3.5

8.7

114

J01FA09

ATC

clarithromycin; systemic

1.3

8.6

680

5438

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.6

8.6

104

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

8.6

131

722

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.2

8.6

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

4.6

8.6

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

11.6

8.6

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.9

8.6

175

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

8.5

246

Z51.88

ICD-10 Finland

Other specified medical care

2.7

8.5

205

L17

ICPC

Foot/toe symptom/complaint

1.4

8.5

558

4339

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.7

8.5

212

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

8.5

929

7780

130

Kela drug reimbursment

Malignant tumour

1.6

8.5

202

1275

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

8.5

251

1673

QDG10

NOMESCO Finland

Excision and repair of bedsore of lower limb

20.1

8.5

K50.8

ICD-10 Finland

Other Crohn disease

3.3

8.5

127

TNG10

NOMESCO Finland

Puncture of knee

4.1

8.4

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.3

8.4

333

H04AA01

ATC

glucagon; nasal, parenteral

2.5

8.4

249

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

8.4

169

1017

N17.8

ICD-10 Finland

Other acute renal failure

3.5

8.4

106

R06AE07

ATC

cetirizine; oral

1.3

8.4

968

8153

T89

ICPC

Diabetes insulin dependent

2.1

8.4

424

WW300

NOMESCO Finland

Transfer of autologic stem cells

7.3

8.4

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.3

8.4

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.0

8.4

155

WX882

NOMESCO Finland

High dependency care

2.4

8.4

306

2AX04

NOMESCO Finland

90.3

8.4

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.8

8.4

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.7

8.4

UJF92

NOMESCO Finland

Capsular endoscopy

2.7

8.4

201

J04AB02

ATC

rifampicin; systemic

3.2

8.4

128

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

8.3

124

677

K65.8

ICD-10 Finland

Other peritonitis

10.8

8.3

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

10.8

8.3

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

8.3

366

2655

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

8.3

397

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

8.3

120

650

R03AC02

ATC

salbutamol; inhalant

1.3

8.2

1222

10619

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.3

8.2

119

S29

ICPC

Skin symptom/complaint other

1.4

8.2

372

2711

J01XE01

ATC

nitrofurantoin; oral

2.8

8.2

190

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.7

8.2

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

8.2

739

6020

A27

ICPC

Fear of other disease NOS

2.0

8.2

101

515

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

8.2

105

542

J01CF05

ATC

flucloxacillin; systemic

2.0

8.1

490

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.1

8.1

418

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.0

8.1

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

8.1

834

6913

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

5.7

8.1

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

8.1

612

4862

A10AA02

ATC

2.0

8.0

485

D07AA02

ATC

hydrocortisone; topical

1.5

8.0

299

2096

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

8.0

384

2825

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.4

8.0

273

R4180

NOMESCO Finland

Podiatric therapy

3.9

8.0

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

8.9

8.0

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.1

8.0

138

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

22.1

8.0

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.9

8.0

166

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

8.0

140

807

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.0

241

1613

A07EC02

ATC

mesalazine; oral, rectal

1.8

8.0

122

675

J01XX05

ATC

methenamine; oral

3.5

8.0

101

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

7.9

131

744

SPAT1342

SPAT

Referral to specialised care

3.2

7.9

123

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

7.9

121

669

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.5

7.9

251

C83.1

ICD-10 Finland

Mantle cell lymphoma

6.6

7.9

Catheterization and pressure measurement of the left side of the heart

2.5

7.9

241

WVA20

NOMESCO Finland

Medicine administration

2.5

7.8

234

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.5

7.8

223

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

3.9

7.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

7.8

425

WX213

NOMESCO Finland

Lower leg blockade

4.3

7.8

D11

ICPC

Diarrhoea

1.6

7.8

227

1506

R4120

NOMESCO Finland

Occupational therapy

1.7

7.8

147

867

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

7.8

124

696

N05AA02

ATC

levomepromazine; systemic

1.9

7.8

102

534

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

7.7

298

2101

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.9

7.7

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

7.7

247

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

7.7

274

1901

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.7

772

6372

R02

ICPC

Shortness of breath/dyspnoea

1.5

7.7

278

1934

D46.2

ICD-10 Finland

Refractory anaemia with excess of blasts [RAEB]

15.0

7.7

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

5.0

7.7

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

6.4

7.7

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.9

7.7

151

R10.0

ICD-10 Finland

Acute abdomen

2.2

7.7

349

M54.5

ICD-10 Finland

Low back pain

1.3

7.7

714

5832

M10.0

ICD-10 Finland

Idiopathic gout

2.0

7.7

445

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.7

7.7

181

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.1

7.7

126

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

7.4

7.7

R50.1

ICD-10 Finland

Persistent fever

7.4

7.7

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.5

7.6

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.9

7.6

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.8

7.6

C03AA03

ATC

hydrochlorothiazide; oral

1.5

7.6

231

1546

K83.1

ICD-10 Finland

Obstruction of bile duct

3.1

7.6

132

A07EA06

ATC

budesonide; oral, local oral

2.2

7.6

354

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.6

7.6

207

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

7.6

199

1285

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.1

7.6

402

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

7.6

225

RS222

NOMESCO Finland

3.2

7.6

116

D01

ICPC

Abdominal pain/cramps general

1.5

7.6

220

1461

C83.00

ICD-10 Finland

Lymphocytic lymphoma

8.9

7.5

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

8.9

7.5

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.3

7.5

106

L04AX04

ATC

lenalidomide; oral

5.4

7.5

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

7.5

512

A97

ICPC

No disease

1.4

7.5

314

2256

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.8

7.5

132

764

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

7.5

514

NF3AA

NOMESCO Finland

Femur X-ray examination

2.6

7.5

203

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

7.1

7.5

A02BA02

ATC

ranitidine; systemic

1.4

7.5

475

3670

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

7.5

893

7534

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

7.4

117

652

M46.4

ICD-10 Finland

Discitis, unspecified

4.8

7.4

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.6

7.4

211

1392

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

7.4

223

1493

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

7.4

527

4141

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

7.4

124

K56.7

ICD-10 Finland

Ileus, unspecified

2.7

7.4

181

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.6

7.4

197

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.5

7.4

231

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

13.4

7.4

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.4

552

4373

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

7.4

158

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.1

7.4

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

7.4

155

947

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.7

7.3

174

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.9

7.3

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.6

7.3

199

I50

ICD-10 Finland

Heart failure

2.0

7.3

459

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.9

7.3

145

L03AA14

ATC

lipegfilgrastim; parenteral

2.7

7.3

176

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.9

7.3

R03AC12

ATC

salmeterol; inhalant

1.9

7.3

108

592

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

7.3

156

960

XF404

NOMESCO Finland

Ambulatory ECG

1.5

7.3

212

1408

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

7.3

463

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.3

7.2

104

C10AC01

ATC

colestyramine; oral

2.2

7.2

298

TK820

NOMESCO Finland

Peritoneal dialysis

5.8

7.2

JAH00

NOMESCO Finland

Laparotomy

2.2

7.2

319

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

7.2

353

N04BC05

ATC

pramipexole; oral

1.7

7.2

157

970

B01AC04

ATC

clopidogrel; oral

1.4

7.2

394

2973

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.1

7.2

A10AA01

ATC

2.2

7.2

312

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

7.1

394

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

7.1

334

S70.0

ICD-10 Finland

Contusion of hip

1.9

7.1

501

D64.8

ICD-10 Finland

Other specified anaemias

2.8

7.1

156

S06.0

ICD-10 Finland

Concussion

1.5

7.1

231

1573

I20.09

ICD-10 Finland

Unstable angina

1.7

7.1

154

948

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

7.1

282

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

3.5

7.1

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

12.0

7.1

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

6.0

7.1

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

7.0

239

1646

D07AC01

ATC

betamethasone; topical

1.3

7.0

781

6521

WX872

NOMESCO Finland

Intensive care

1.8

7.0

112

631

WNF00

NOMESCO Finland

Infection source and contact determination

4.7

7.0

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.6

7.0

176

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.3

7.0

102

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.9

6.9

139

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

6.9

192

1261

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.5

6.9

212

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

6.9

807

6776

78880

ICD-8 Finland

Other general symptoms, Pyrexia of unknown origin

5.2

6.9

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.1

6.9

346

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.9

485

3803

G82.2

ICD-10 Finland

Paraplegia, unspecified

5.8

6.9

WX610

NOMESCO Finland

Patient controlled analgesia

4.2

6.9

T87.4

ICD-10 Finland

Infection of amputation stump

13.8

6.9

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.0

6.9

451

C09CA06

ATC

candesartan; oral

1.3

6.9

467

3640

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.2

6.9

293

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.1

6.9

351

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.9

6.9

M25.5

ICD-10 Finland

Pain in joint

1.3

6.9

579

4663

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.7

6.9

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.3

6.8

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.4

6.8

215

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.6

6.8

172

153

Kela drug reimbursment

Lenalidomid

4.8

6.8

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

6.8

318

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.7

6.8

155

W19

ICD-10 Finland

Unspecified fall

1.5

6.8

216

1466

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.9

6.8

135

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

6.8

431

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.4

6.8

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

6.8

223

1524

YNB10

NOMESCO Finland

Collection of stem cells for transplant

10.9

6.8

C50.99

ICD-10 Finland

Breast, unspecified

2.3

6.8

266

C10AA01

ATC

simvastatin; oral

1.2

6.8

1068

9283

JJC00

NOMESCO Finland

Allogenic transplantation of liver

9.3

6.8

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

6.8

121

B07.9

ICD-10 Finland

Verruca simplex

2.1

6.8

333

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

6.1

6.8

Q61.1

ICD-10 Finland

Polycystic kidney, autosomal recessive

40.1

6.8

J02AC04

ATC

posaconazole; systemic

40.1

6.8

7531A

ICD-9 Finland

Congenital anomalies of urinary system, Cystic kidney disease

40.1

6.8

JKA20

NOMESCO Finland

Cholecystectomy

2.1

6.7

334

WX402

NOMESCO Finland

General anaesthesia

1.4

6.7

333

2468

H25.8

ICD-10 Finland

Other senile cataract

1.5

6.7

256

1804

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.0

6.7

122

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

4.7

6.7

M35.1

ICD-10 Finland

Other overlap syndromes

4.7

6.7

J01MA01

ATC

ofloxacin; systemic

1.5

6.7

210

1418

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

6.7

219

J43.9

ICD-10 Finland

Emphysema, unspecified

2.7

6.7

161

N06AB06

ATC

sertraline; oral

1.5

6.7

211

1429

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.8

6.6

146

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

6.6

379

129

Kela drug reimbursment

Idiopathic thrombocytopaenia or granulocytopenia

7.8

6.6

6BA02

NOMESCO Finland

5.9

6.6

I20.00

ICD-10 Finland

Unstable angina

1.9

6.6

503

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.5

6.6

206

Z29

ICPC

Social problem NOS

2.5

6.6

188

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.5

6.6

188

R05

ICD-10 Finland

Cough

1.4

6.6

404

3099

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

6.6

113

650

B37.7

ICD-10 Finland

Candidal sepsis

8.7

6.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

6.5

423

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

6.5

208

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.7

6.5

157

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.5

6.5

190

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

6.5

175

1141

N06AX03

ATC

mianserin; oral

1.8

6.5

100

557

Angiography of the heart and coronary arteries

1.6

6.5

178

1165

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

5.0

6.5

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

6.5

143

885

C10AA05

ATC

atorvastatin; oral

1.2

6.5

878

7492

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.0

6.5

XQ902

NOMESCO Finland

Other photography

4.5

6.5

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.8

6.4

112

646

Z75.5

ICD-10 Finland

Holiday relief care

3.1

6.4

103

A86

ICD-10 Finland

Unspecified viral encephalitis

5.7

6.4

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

6.4

391

F20.4

ICD-10 Finland

Post-schizophrenic depression

70.0

6.4

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

14.3

6.4

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

14.3

6.4

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

1.8

6.4

106

606

SPAT1211

SPAT

Application of soft bandage

1.5

6.3

206

1403

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

6.3

298

N03AX14

ATC

levetiracetam; systemic

2.2

6.3

277

105

Kela drug reimbursment

Adrenal cortical hypofunction

6.5

6.3

ZX121

NOMESCO Finland

Central venous catheter

6.5

6.3

A21.9

ICD-10 Finland

Tularaemia, unspecified

8.2

6.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

6.3

487

3868

K65.9

ICD-10 Finland

Peritonitis, unspecified

6.0

6.3

E000003

ATC

1.8

6.3

102

579

TPX15

NOMESCO Finland

Removal of vascular injection port

5.5

6.3

A49

ICD-10 Finland

Bacterial infection of unspecified site

5.5

6.3

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.5

6.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.2

6.3

R18

ICD-10 Finland

Ascites

2.5

6.3

188

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

6.3

195

1316

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

6.3

123

739

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.4

6.3

207

AA1AA

NOMESCO Finland

Head X-ray examination

3.8

6.3

N03.3

ICD-10 Finland

Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis

18.0

6.3

75310

ICD-8 Finland

Congenital anomalies of urinary system, Ren polycysticus bilateralis

+∞

6.2

K85

ICD-10 Finland

Acute pancreatitis

2.5

6.2

189

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

6.2

196

1327

C07FB02

ATC

metoprolol and felodipine; systemic

2.0

6.2

367

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.8

6.2

522

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.0

6.2

106

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

7.0

6.2

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

7.0

6.2

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

6.2

261

Z22.3

ICD-10 Finland

Carrier of other specified bacterial diseases

6.3

6.2

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

6.3

6.2

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.1

6.1

309

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

5.3

6.1

306

Kela drug reimbursment

Erythropoietin and darbepoetin

5.7

6.1

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

5.7

6.1

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

2.5

6.1

177

S72.0

ICD-10 Finland

Fracture of neck of femur

1.8

6.1

104

599

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.1

174

1153

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

7.7

6.1

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

7.7

6.1

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

7.7

6.1

A87.9

ICD-10 Finland

Viral meningitis, unspecified

4.2

6.1

K02.9

ICD-10 Finland

Dental caries, unspecified

2.6

6.1

160

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

6.1

311

2315

N05AA01

ATC

chlorpromazine; systemic, rectal

2.9

6.1

122

M48.0

ICD-10 Finland

Spinal stenosis

1.4

6.1

263

1900

M01AE02

ATC

naproxen; oral, rectal

1.2

6.1

1275

11381

UJD02

NOMESCO Finland

Gastroscopy

1.7

6.1

111

654

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

4.7

6.1

R52.2

ICD-10 Finland

Other chronic pain

2.0

6.1

388

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

4.0

6.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.1

242

1720

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.3

6.1

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.0

6.0

380

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.5

6.0

171

R03BA05

ATC

fluticasone; inhalant

1.3

6.0

379

2917

J01DC02

ATC

cefuroxime; systemic

1.7

6.0

117

700

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.8

6.0

124

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.7

6.0

147

AB1

AVR mechanical

5.2

6.0

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

1545

7240

3.23

224.82

8.3

4.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

986

4327

2.86

149.11

2.8

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

548

1824

3.43

132.49

2.2

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

248

468

5.67

126.17

7.4

5.2

815.1

784.8

iu/ml

0.02

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

730

3008

2.86

121.18

2.4

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

724

3005

2.83

118.25

2.3

1.7

—

(3002032) Base excess in Venous blood by calculation

622

2431

2.94

113.15

7.3

3.6

1.6

1.9

mmol/l

1.20

519

1933

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

374

1095

3.74

109.01

2.6

1.9

2.4

ug/l

0.02

343

952

(3012544) pH of Venous blood

627

2510

2.87

108.78

7.0

3.6

7.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

615

2441

2.89

108.37

7.2

3.6

5.7

5.8

kpa

1.51

603

2366

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

268

620

4.63

107.39

2.5

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

200

365

5.78

105.19

3.7

3.0

270.4

2155.0

u/ml

1.17

(3002582) Erythrocytes [#/volume] in Urine

1336

7710

2.28

105.09

5.2

3.3

59.0

79.1

e6/l

0.57

1143

5995

(3022096) Basophils/100 leukocytes in Blood

1720

11088

2.22

101.97

10.5

5.9

0.6

0.7

4.51

1640

10325

(42870588) Differential panel, method unspecified - Blood

1397

8318

2.23

100.62

9.8

5.7

—

(3006504) Eosinophils/100 leukocytes in Blood

1749

11424

2.20

99.36

10.6

5.8

2.7

2.8

1.60

1665

10620

(3019069) Monocytes/100 leukocytes in Blood

1753

11476

2.20

98.81

10.9

6.1

8.8

8.7

0.70

1675

10723

(3030467) Casts [#/volume] in Urine by Automated count

1224

7003

2.23

96.27

5.1

3.2

0.4

0.5

e6/l

0.42

1024

5355

(3002030) Lymphocytes/100 leukocytes in Blood

1769

11769

2.15

93.78

10.8

6.0

24.9

27.2

12.97

1689

10944

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

209

441

5.01

93.38

2.6

1.6

—

(3026782) Osmolality of Urine

970

5107

2.30

92.68

4.5

2.8

534.3

552.6

mosm/kgh2o

1.82

881

4357

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

245

592

4.40

92.66

2.6

1.6

—

(3006315) Basophils [#/volume] in Blood

1804

12169

2.14

91.26

10.1

5.6

0.0

e9/l

2.33

1632

10494

(3003458) Phosphate [Moles/volume] in Serum or Plasma

722

3358

2.49

91.18

13.1

5.6

1.1

1.0

mmol/l

5.68

688

3109

(3001604) Monocytes [#/volume] in Blood

1795

12116

2.13

90.25

10.0

5.6

0.6

e9/l

3.42

1618

10447

(3018095) Leukocytes [#/volume] in Urine

1437

8925

2.13

90.02

5.8

3.8

93.0

112.6

e6/l

0.26

1173

6419

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

657

2939

2.56

90.01

6.1

4.0

245.8

247.8

u/l

0.10

634

2769

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

183

359

5.35

88.82

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

281

779

3.86

88.11

1.6

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

561

2349

2.69

87.77

15.3

6.9

11.6

10.4

mmol/l

3.26

542

2223

(3019198) Lymphocytes [#/volume] in Blood

1820

12477

2.09

86.17

10.3

5.7

1.8

1.9

e9/l

0.30

1663

10954

(3013115) Eosinophils [#/volume] in Blood

1830

12584

2.09

85.76

10.6

5.9

0.2

e9/l

1.23

1660

10997

(3018010) Neutrophils/100 leukocytes in Blood

1723

11593

2.08

85.61

10.3

5.7

59.9

57.8

9.39

1649

10826

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1855

12854

2.08

84.71

11.0

6.0

11.6

12.0

umol/l

0.39

1793

12169

(3042936) Bacteria identified in Isolate by Culture

734

3543

2.40

84.70

2.8

2.0

—

(3000850) Epithelial cells [#/volume] in Urine

991

5445

2.20

83.87

4.3

2.6

5.1

5.4

e6/l

0.27

917

4798

(3024354) Oxygen [Partial pressure] in Venous blood

499

2023

2.74

82.86

6.2

3.1

5.0

4.5

kpa

3.53

490

1955

(3013650) Neutrophils [#/volume] in Blood by Automated count

1976

14104

2.08

82.13

16.8

8.6

4.5

4.2

e9/l

4.32

1807

12284

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

155

284

5.69

80.99

1.9

1.6

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

714

3472

2.37

80.57

4.8

2.6

21.1

22.5

1.68

639

2961

(3004789) Transferrin [Mass/volume] in Serum or Plasma

746

3711

2.33

79.78

4.7

2.5

2.2

2.3

g/l

10.41

711

3416

(3022948) Iron [Moles/volume] in Serum or Plasma

778

4029

2.24

74.99

4.7

2.5

11.0

12.7

umol/l

8.00

735

3708

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

189

440

4.51

74.74

1.9

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

177

392

4.73

74.46

1.9

1.4

110.8

120.5

u/ml

0.32

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

189

444

4.47

73.87

1.9

1.4

—

15.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

776

4038

2.22

73.77

5.6

3.2

0.8

mmol/l

5.50

737

3772

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

217

570

4.02

73.15

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

217

570

4.02

73.15

1.7

1.3

—

(36304419) Bacteria [Presence] in Urine

1132

6830

2.03

72.66

5.0

3.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

400

1566

2.78

70.43

1.7

1.5

—

(3000991) Gas panel - Venous blood

493

2166

2.51

68.67

11.2

8.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1228

7739

1.96

68.65

4.7

3.1

32.3

36.8

u/l

1.13

1172

7353

(3005719) IgG [Mass/volume] in Serum or Plasma

428

1762

2.65

68.18

3.8

2.8

10.2

10.7

g/l

1.31

401

1599

(3009445) Proteinase 3 Ab [Units/volume] in Serum

296

1010

3.13

66.68

1.6

1.4

13.1

20.5

u/ml

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1744

12459

1.90

65.66

14.3

6.7

1.2

mmol/l

0.79

1486

10443

(3024561) Albumin [Mass/volume] in Serum or Plasma

1565

10799

1.90

65.60

8.9

4.7

33.6

35.2

g/l

18.97

1480

10006

(3026008) Bacteria identified in Urine by Culture

1211

7696

1.93

65.20

4.6

3.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

745

4021

2.12

63.28

3.9

3.0

2.3

2.2

e6/l

0.04

456

2225

(3032080) INR in Blood by Coagulation assay

1512

10408

1.87

62.97

17.7

9.9

1.3

inr

0.20

454

2964

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

774

4270

2.08

61.84

3.7

2.8

1.3

1.2

e6/l

0.23

485

2461

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1194

7696

1.89

60.43

3.7

2.5

52.9

57.1

u/l

3.25

1138

7077

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

170

430

4.12

60.21

1.5

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

324

1230

2.82

60.11

7.9

3.9

23.9

24.0

mmol/l

0.35

297

1107

(3013826) Glucose [Moles/volume] in Serum or Plasma

1954

14707

1.87

60.05

9.3

4.8

7.0

6.8

mmol/l

2.90

1876

13766

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

163

401

4.23

59.91

1.5

1.3

307.2

257.0

u/ml

1.05

116

245

(3028026) IgM [Mass/volume] in Serum or Plasma

351

1395

2.71

59.61

2.0

1.9

1.2

1.4

g/l

1.34

315

1271

(3014576) Chloride [Moles/volume] in Serum or Plasma

625

3227

2.17

59.09

10.5

6.8

104.2

104.4

mmol/l

0.49

611

3144

(3027273) Bicarbonate [Moles/volume] in Venous blood

329

1280

2.75

58.19

6.5

3.3

25.0

25.1

mmol/l

0.36

324

1240

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

155

383

4.21

56.62

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

373

1569

2.56

56.35

6.6

3.1

123.5

128.1

g/l

3.59

368

1528

(3014111) Lactate [Moles/volume] in Serum or Plasma

481

2289

2.30

55.23

9.0

6.9

1.3

1.4

mmol/l

0.39

470

2202

(3018677) aPTT in Platelet poor plasma by Coagulation assay

707

3950

2.02

53.58

2.8

2.2

30.6

30.0

1.54

690

3822

(3048929) Epstein Barr virus Ab [Presence] in Serum

207

649

3.34

53.41

1.5

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

7.79

53.15

27.4

26.9

100.6

118.4

ug/l

1.36

(3027945) Reticulocytes/100 erythrocytes in Blood

587

3075

2.12

52.91

3.4

2.5

1.8

0.54

551

2702

(3007853) Bacteria identified in Skin by Aerobe culture

569

2961

2.13

52.11

2.5

1.8

—

(3018418) pH of Serum or Plasma

1121

7358

1.81

51.52

9.1

3.9

7.4

0.26

241

1410

(3026250) Tacrolimus [Mass/volume] in Blood

7.79

51.03

39.8

35.5

7.3

7.0

ug/l

0.46

(40758558) Short blood count panel - Blood

978

6176

1.85

50.86

12.5

6.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

160

438

3.80

50.70

4.9

3.5

1.4

1.6

0.18

119

331

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

412

1912

2.33

49.87

7.3

3.8

136.4

92.8

ng/l

4.24

355

1638

(3024891) Influenza virus A+B Ag [Presence] in Specimen

203

659

3.22

49.45

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

103

207

5.11

48.51

2.0

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

352

1543

2.44

48.40

8.9

7.9

24.4

24.8

mmol/l

0.74

346

1533

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

302

1233

2.60

48.25

1.9

1.7

1.8

1.5

g/l

3.70

266

1054

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

226

798

2.97

47.63

1.7

1.5

424.4

248.3

titre

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

154

429

3.72

47.57

1.7

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

133

336

4.09

47.13

1.6

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

454

2274

2.17

45.42

4.0

2.6

68.5

69.3

e9/l

0.17

344

1748

(3021589) Normoblasts [#/volume] in Blood

1465

10652

1.70

45.28

18.8

9.6

0.0

e9/l

0.93

1238

8716

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

455

2288

2.16

45.04

3.6

2.4

38.2

59.9

u/l

0.50

396

1949

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

522

2772

2.06

44.73

4.5

2.7

9.8

8.6

umol/l

0.41

458

2411

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

808

4982

1.84

44.35

5.2

3.8

246.4

437.3

ng/l

2.07

660

4008

(46235355) HIV 1 and 2 tests - Meaningful Use set

673

3917

1.91

44.26

2.4

1.8

—

(1616796) Gas panel - Central venous blood

180

583

3.21

43.96

5.3

3.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

197

680

3.02

43.16

6.8

4.4

—

(3044640) Blood type and Crossmatch panel - Blood

1145

7899

1.71

42.14

3.9

2.5

—

(3017181) Myelocytes/100 leukocytes in Blood

415

2065

2.16

42.03

5.8

4.1

0.9

0.00

192

627

(3017143) Hepatitis C virus Ab [Presence] in Serum

481

2554

2.04

40.96

2.4

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

427

2169

2.12

40.95

3.3

2.6

64.5

66.3

g/l

4.72

393

1980

(3031040) Bacteria [#/volume] in Urine by Automated count

2040

16434

1.69

40.91

6.9

4.7

52.5

1843.9

e6/l

3.09

277

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

280

1192

2.48

40.80

7.6

3.9

48.6

47.9

0.17

280

1178

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

123

330

3.84

40.09

1.7

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

264

4.16

39.14

3.1

1.6

—

(3000330) Specific gravity of Urine by Test strip

295

1313

2.38

38.92

6.1

3.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

132

380

3.58

38.82

1.7

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

993

6714

1.70

38.61

3.0

2.2

3.3

3.0

mg/l

2.64

872

5691

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

182

640

2.96

38.55

2.1

1.5

0.2

g/l

0.04

169

606

(3025941) Bacteria identified in Stool by Culture

293

1309

2.37

38.31

1.5

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2079

16981

1.67

38.03

7.2

4.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1095

7631

1.67

37.78

2.7

2.2

181.3

230.4

u/l

1.21

1059

7138

(3033705) Calcium.ionized [Moles/volume] in Venous blood

119

326

3.75

37.65

4.0

2.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1497

11294

1.62

37.56

12.5

6.0

1.2

mmol/l

2.94

1413

10168

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

124

350

3.65

37.55

9.1

6.6

12.0

11.8

mg/l

0.19

116

324

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2256

18853

1.70

37.51

15.5

7.3

90.1

79.4

u/l

9.46

2181

17726

(40760892) CBC W Ordered Manual Differential panel - Blood

816

5266

1.74

37.37

7.1

4.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

190

696

2.84

37.34

4.1

3.4

24.1

24.9

mmol/l

1.35

168

603

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

184

665

2.88

37.07

2.1

1.5

1.2

g/l

0.03

172

628

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

242

4.19

36.66

3.2

1.6

—

(3033658) Prothrombin time (PT) actual/Normal

928

6247

1.69

36.23

7.2

4.0

86.1

87.2

0.63

905

6089

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

220

888

2.59

35.76

2.4

2.2

350.4

487.1

ug/l

0.59

204

836

(21494815) CD4 cells/100 lymphocytes in Specimen

189

4.59

35.53

2.5

2.2

39.0

45.2

0.51

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

817

5340

1.72

35.45

2.3

1.7

1.3

mg/l

0.20

655

4095

(3028626) Oxygen [Partial pressure] in Capillary blood

177

642

2.86

35.42

4.2

8.0

kpa

0.12

168

592

(3021440) Promyelocytes/100 leukocytes in Blood

382

1960

2.08

35.41

5.9

4.1

0.1

0.34

182

579

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1407

10558

1.60

35.36

4.6

2.8

182.3

132.1

ug/l

4.81

1321

9699

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.58

35.35

3.5

2.6

—

(3037522) Nuclear Ab [Titer] in Serum

531

3066

1.88

34.97

1.5

1.3

517.5

516.5

titre

0.00

128

645

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

225

4.23

34.92

3.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

225

4.23

34.92

3.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

225

4.23

34.92

3.4

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

367

1867

2.09

34.78

5.6

3.9

0.6

0.05

132

441

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

423

2276

1.99

34.33

4.0

3.0

287.7

233.8

ng/l

1.25

387

2071

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

241

4.08

34.32

1.2

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

222

919

2.52

34.22

4.4

3.4

0.3

u/ml

0.50

130

522

(44790049)

107

291

3.77

34.22

1.7

1.6

—

(44806118)

107

291

3.77

34.22

1.7

1.6

—

(44790047)

107

291

3.77

34.22

1.7

1.6

—

(44790048)

107

291

3.77

34.22

1.7

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

955

6556

1.66

34.20

4.3

2.7

4996.2

5844.1

umol/l

0.25

860

5639

(3011412) CD3 cells [#/volume] in Blood

216

4.26

34.15

2.9

2.3

1.0

1.1

e9/l

0.19

128

(3023183) Ammonium ion [Moles/volume] in Plasma

154

530

3.00

33.87

2.7

2.8

37.0

36.9

umol/l

0.02

124

442

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

191

745

2.67

33.25

2.1

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

140

463

3.12

32.99

1.4

1.2

60.0

335.6

titre

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

4.72

32.95

1.8

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

209

858

2.54

32.77

2.6

2.7

—

(3021901) Oxygen saturation in Capillary blood

148

508

3.01

32.70

3.9

2.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

154

543

2.93

32.44

1.6

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

173

651

2.75

32.29

4.8

4.0

2.1

1.6

mg/l

5.61

157

582

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

421

2311

1.95

32.13

3.0

2.2

0.2

g/l

0.39

387

2149

(3035350) Ketones [Presence] in Urine by Test strip

1541

11986

1.56

32.03

5.7

3.7

0.0

estimate

0.00

303

2238

(3004588) Protein electrophoresis panel - Serum or Plasma

352

1816

2.06

32.01

2.7

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

545

3254

1.82

32.00

2.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

128

5.16

31.36

4.2

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

128

5.16

31.36

4.2

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

128

5.16

31.36

4.2

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

128

5.16

31.36

4.2

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1553

12138

1.55

31.33

5.8

3.8

0.0

estimate

0.80

298

2201

(3010421) pH of Blood

180

704

2.65

31.15

7.2

4.4

7.4

0.09

154

590

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

141

4.91

30.92

1.9

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

141

4.91

30.92

1.8

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

1535

12002

1.55

30.66

8.3

5.0

0.0

estimate

0.41

308

2280

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

462

2663

1.86

30.26

6.1

3.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

329

1690

2.06

30.21

5.5

4.1

5.1

5.2

kpa

1.04

307

1555

(3012501) Base excess in Blood by calculation

160

599

2.76

30.15

6.7

4.7

2.5

2.7

mmol/l

0.25

121

400

(3035947) Staphylolysin Ab [Units/volume] in Serum

114

5.35

30.12

1.3

1.1

3.2

5.2

iu/ml

—

(3027315) Oxygen [Partial pressure] in Blood

160

600

2.76

30.06

6.7

4.7

8.0

8.5

kpa

2.75

153

590

(3013290) Carbon dioxide [Partial pressure] in Blood

160

600

2.76

30.06

6.7

4.7

5.0

kpa

0.54

153

591

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

233

3.90

30.06

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

247

3.81

29.99

2.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

396

2178

1.94

29.93

2.3

2.2

369.1

374.2

nmol/l

0.13

370

1980

(3021879) Hepatitis B virus core Ab [Presence] in Serum

320

1636

2.06

29.75

1.9

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1054

7613

1.58

29.72

4.2

3.1

2507.0

1738.8

ng/l

3.68

943

6529

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

170

663

2.65

29.58

1.8

1.3

—

(3009343) pH of Capillary blood

323

1668

2.04

29.20

5.5

4.1

7.4

0.01

198

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

314

1606

2.06

29.14

5.4

4.0

2.0

1.8

mmol/l

0.27

219

1177

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

413

2344

1.88

28.29

3.0

2.4

7.2

7.0

ug/l

0.05

374

2031

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.82

27.57

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

172

704

2.53

27.11

3.5

2.6

3.6

g/l

0.05

166

663

(3025159) Blasts/100 leukocytes in Blood

340

1834

1.96

27.10

5.7

4.1

0.4

0.5

0.10

137

476

(3003396) Base excess in Arterial blood by calculation

490

2986

1.76

26.44

9.5

7.2

0.9

1.1

mmol/l

0.36

383

2317

(3017354) Segmented neutrophils/100 leukocytes in Blood

271

3.47

26.17

5.7

3.4

62.7

56.5

1.21

170

(3042733) HLA Ab [Presence] in Serum

6.54

26.00

5.2

4.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1010

2.24

26.00

2.5

2.3

3.8

g/l

0.01

146

735

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1011

2.24

25.93

2.5

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1012

2.24

25.87

2.5

2.3

7.9

7.4

g/l

3.07

154

768

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

132

485

2.80

25.79

5.0

3.7

59.1

58.3

0.23

132

485

(3007164) IgA [Mass/volume] in Serum or Plasma

665

4441

1.63

25.36

1.7

1.5

2.5

g/l

0.22

460

2703

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1278

9874

1.50

25.33

3.1

2.2

76.4

77.3

nmol/l

0.48

1178

8746

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

222

1049

2.20

25.22

5.6

5.1

1.7

1.6

0.37

209

978

(3052851) Hemolysis interference index of Serum or Plasma

177

760

2.41

25.16

4.1

3.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

130

481

2.78

25.07

1.7

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1454

11550

1.48

24.99

6.6

4.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

189

838

2.34

24.99

3.6

3.4

53.4

73.6

mg/l

0.48

138

686

(3007930) Methemoglobin/Hemoglobin.total in Blood

220

1040

2.20

24.96

5.7

5.2

0.9

0.39

207

970

(3019309) Folate [Moles/volume] in Red Blood Cells

738

5077

1.59

24.83

2.1

1.8

1192.2

1180.2

nmol/l

0.11

600

3834

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

206

952

2.25

24.70

2.5

2.3

10.4

10.3

g/l

0.18

179

810

(3016502) Oxygen saturation in Arterial blood

442

2667

1.77

24.56

10.0

7.6

95.3

95.4

0.05

419

2570

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

183

812

2.33

24.15

3.7

3.4

1.9

1.7

ratio

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

303

1633

1.95

24.12

2.1

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.73

24.11

11.4

15.1

4.6

6.4

mmol/l

1.76

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

481

2989

1.72

24.05

9.6

7.2

5.0

5.1

kpa

1.25

460

2838

(3027801) Oxygen [Partial pressure] in Arterial blood

481

2989

1.72

24.05

9.6

7.1

11.3

12.0

kpa

3.22

460

2841

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

237

3.53

24.03

1.2

68.7

67.8

u/l

0.01

159

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

110

381

2.96

23.95

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

219

3.63

23.87

1.3

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

186

837

2.30

23.76

3.7

3.4

58.3

57.8

mg/l

0.02

138

682

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

148

601

2.53

23.72

2.4

2.0

12.6

11.8

mg/l

0.43

138

550

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

128

4.52

23.59

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

128

4.52

23.59

1.1

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

142

4.29

23.25

1.4

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

124

468

2.72

23.03

4.2

3.4

4.3

e9/l

0.02

124

468

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

224

1101

2.11

23.00

3.7

1.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

165

4.00

22.96

3.5

2.1

625.3

729.1

e6/l

0.46

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1250

9768

1.46

22.62

5.8

3.9

45.2

55.3

ng/l

0.80

950

6956

(3006922) Hepatitis E virus Ab [Presence] in Serum

137

4.29

22.54

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

144

592

2.50

22.50

1.4

456.3

526.0

mg/l

1.83

135

557

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

355

2058

1.82

22.48

8.3

3.7

1.2

mmol/l

0.34

336

1775

(3022217) INR in Platelet poor plasma by Coagulation assay

547

3583

1.64

22.24

25.5

27.5

1.3

1.4

inr

1.90

121

495

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

418

2551

1.74

22.19

4.3

4.0

24.0

22.2

ug/l

0.07

337

2103

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

166

3.91

21.96

2.0

2.3

13.1

13.7

0.08

(3002173) Hemoglobin [Mass/volume] in Arterial blood

403

2444

1.74

21.86

10.6

7.9

117.2

121.3

g/l

3.41

385

2350

(40760888) Immunoglobulin light chains.free panel - Serum

149

632

2.43

21.77

3.7

3.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

154

4.02

21.72

2.0

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

131

526

2.56

21.51

1.6

112.6

719.1

e6/l

1.63

106

431

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

131

526

2.56

21.51

1.5

11.7

28.6

e6/l

0.73

101

411

(40767503) Oxygen content in Capillary blood by calculation

136

559

2.50

21.27

3.8

2.5

15.6

16.0

0.39

282

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

104

375

2.83

21.08

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

188

894

2.17

21.00

3.1

269.7

4870.8

u/ml

0.85

157

757

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

181

3.70

20.94

1.9

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

101

360

2.87

20.91

1.2

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

164

739

2.29

20.88

2.8

2.7

93.0

90.2

0.74

155

699

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

4.30

20.65

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

203

1003

2.09

20.55

2.8

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

112

427

2.68

20.42

1.4

1.2

—

(3024928) Oxygen saturation in Venous blood

128

526

2.49

20.03

6.8

2.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

4.94

19.91

1.9

2.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

155

3.86

19.91

3.3

2.2

540.4

543.2

e6/l

0.01

133

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.69

19.61

5.3

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.69

19.61

5.3

1.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

139

4.01

19.58

1.2

1.1

109.7

91.7

u/l

0.51

118

(3028271) Lactate [Moles/volume] in Capillary blood

110

426

2.64

19.46

2.7

2.0

1.5

1.7

mmol/l

1.58

110

417

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.68

19.45

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

154

698

2.27

19.35

1.7

1.6

0.4

9.6

iu/ml

0.55

142

(3013707) Erythrocyte sedimentation rate by Westergren method

2061

17950

1.43

19.27

6.3

4.0

18.9

12.8

mm/h

35.42

1946

16555

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.60

19.14

5.4

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

818

6041

1.48

19.05

3.9

2.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

126

528

2.44

18.92

1.3

3.9

3.8

mmol/l

0.30

117

491

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

145

647

2.30

18.91

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

352

2.78

18.89

1.5

0.5

0.8

g/l

2.68

269

(3015377) Calcium [Moles/volume] in Serum or Plasma

1079

8411

1.43

18.84

5.0

3.3

2.3

mmol/l

2.30

988

7279

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

149

3.81

18.58

3.4

2.3

0.2

e9/l

0.92

132

(3044290) Cell count panel - Cerebral spinal fluid

116

476

2.49

18.23

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

188

944

2.05

18.22

2.7

2.4

3.5

3.1

g/l

4.82

149

752

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.62

18.20

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

3.89

18.13

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1285

10385

1.40

18.06

2.3

2.0

90.9

93.7

pmol/l

1.40

745

5482

(3024471) HLA-A [Type]

5.27

17.96

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

102

398

2.62

17.80

1.6

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

855

6451

1.45

17.57

5.8

3.4

—

(3024932) HLA-DR beta [Type]

5.27

17.49

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

6.56

17.47

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

130

573

2.32

17.46

2.9

2.3

124.6

128.1

g/l

0.69

101

426

(3021960) Folate [Moles/volume] in Serum or Plasma

803

6003

1.45

17.28

1.8

1.6

18.8

20.1

nmol/l

1.61

726

5117

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

6.41

17.10

2.1

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

240

3.05

16.85

1.6

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

169

843

2.06

16.69

1.3

1.2

2.7

0.8

u/ml

0.57

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.05

16.66

1.8

2.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

111

4.10

16.58

1.4

1.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

275

2.88

16.54

3.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

148

3.63

16.43

2.5

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

242

1372

1.83

16.37

11.4

9.4

24.1

24.3

mmol/l

0.19

229

1275

(3036489) Thrombin time

176

899

2.01

16.29

2.6

2.2

22.1

21.6

0.46

163

800

(3019060) Gas panel - Arterial blood

292

1756

1.73

16.15

6.5

4.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

170

862

2.03

16.06

3.0

2.4

0.5

1.1

g/l

2.04

151

745

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

146

3.60

16.00

2.5

1.3

—

(3004451) EKG impression Narrative

123

3.86

15.99

1.5

1.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

216

3.10

15.95

1.5

1.3

3.0

2.9

g/l

0.14

153

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

186

980

1.95

15.76

2.3

1.8

37.7

38.9

u/l

0.31

167

851

(3003327) Ova and parasites identified in Stool by Light microscopy

151

738

2.10

15.75

2.0

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

153

753

2.08

15.67

2.8

2.2

0.1

0.0

g/l

0.43

142

692

(4062490)

219

3.06

15.59

1.6

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

204

3.13

15.51

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

108

4.02

15.48

2.7

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

108

4.02

15.48

2.7

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

8.38

15.38

2.7

2.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

216

3.05

15.32

1.5

1.3

0.5

0.4

g/l

0.34

151

(3027135) IgG subclass 1 [Mass/volume] in Serum

216

3.05

15.32

1.5

1.3

7.4

7.0

g/l

0.32

152

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.01

15.26

5.9

5.2

—

(3023410) Appearance of Cerebral spinal fluid

238

2.94

15.24

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

128

594

2.20

15.24

1.8

1.6

21495.2

15428.9

e6/l

0.43

430

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.45

15.18

1.3

1.7

—

1632607.1

iu/ml

—

(3048689) Calprotectin [Mass/mass] in Stool

406

2707

1.57

14.93

2.7

2.3

185.7

143.5

ug/g

1.07

342

2125

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

258

2.83

14.85

3.3

2.6

—

(3021788) Differential panel - Synovial fluid

104

447

2.37

14.83

1.5

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.53

14.77

4.5

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

235

1365

1.78

14.66

12.7

10.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

143

704

2.08

14.65

1.4

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1138

9243

1.36

14.60

6.5

4.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.36

14.55

1.3

2.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

114

515

2.26

14.50

2.1

1.4

—

(3020876) Protein [Mass/time] in 24 hour Urine

202

3.06

14.48

2.4

2.0

—

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

143

710

2.06

14.32

1.4

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

102

442

2.35

14.29

2.0

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

144

718

2.05

14.26

1.4

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.62

14.22

4.4

2.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

137

672

2.09

14.18

1.4

—

(3023419) Bacteria identified in Sputum by Culture

323

2.58

14.10

2.8

2.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.02

14.06

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1780

15530

1.34

13.90

4.7

3.1

69.7

50.8

u/l

7.82

1688

14390

(4035726)

320

2052

1.62

13.82

1.5

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

133

3.50

13.59

3.1

3.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

11.71

13.53

3.4

4.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

140

705

2.03

13.51

2.8

2.2

0.0

g/l

0.00

132

653

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

141

712

2.03

13.50

2.8

2.2

0.0

g/l

0.00

132

654

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

139

3.42

13.42

2.8

2.6

37.5

39.0

0.12

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

213

2.90

13.23

1.3

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

206

2.90

12.80

1.2

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

125

616

2.07

12.80

1.4

1.2

150.7

100.2

titre

0.25

(3000494) Fungus identified in Specimen by Culture

405

2790

1.52

12.76

2.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

316

2.51

12.69

5.1

2.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

275

2.62

12.67

1.1

—

(3004775) Volume in Urine collected for unspecified duration

202

2.91

12.65

2.6

2.3

770.9

628.4

1.32

134

(3045142) Bone marrow Pathology biopsy report

276

2.61

12.58

1.5

1.3

—

(3037756) Immunofixation for Serum or Plasma

118

577

2.09

12.35

2.0

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

149

792

1.93

12.34

2.8

2.1

34.9

37.5

g/l

4.48

133

685

(3011397) Hemoglobin [Presence] in Urine by Test strip

735

5692

1.38

12.30

5.1

3.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

240

2.70

12.18

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

3.94

11.99

2.1

1.6

—

(3006270) Folate [Moles/volume] in Blood

231

2.72

11.95

1.2

339.3

369.0

nmol/l

0.44

192

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

150

3.17

11.92

1.7

1.5

7.7

6.1

u/l

0.21

(3047181) Lactate [Moles/volume] in Blood

149

804

1.90

11.81

6.0

1.4

1.3

mmol/l

0.23

124

698

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

300

2.47

11.56

2.4

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

427

2.21

11.44

7.3

3.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

135

713

1.93

11.42

1.3

1.4

271.3

284.5

ug/g

0.30

423

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

298

1966

1.57

11.39

4.8

2.7

55.0

64.0

ml/min/173m2

2.72

146

801

(3044941) Cell count panel - Synovial fluid

396

2.26

11.37

1.5

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

258

1646

1.62

11.35

9.8

6.7

24.1

24.5

mmol/l

0.93

238

1532

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

297

2.46

11.31

2.4

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.46

11.19

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

184

2.86

11.06

1.3

1.2

129.1

titre

0.00

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

613

4681

1.38

11.04

4.2

3.0

2.5

mmol/l

3.01

545

4104

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

131

697

1.92

10.85

2.7

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

155

3.00

10.68

1.3

—

(3016750) Collection duration of Urine

150

3.03

10.65

2.6

2.1

542.4

493.4

min

2.38

110

(40758292) HTLV I+II Ab panel - Serum

5.28

10.58

1.4

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

320

2.34

10.51

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

114

586

1.98

10.45

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

190

2.77

10.44

1.9

1.4

15.4

13.8

u/l

0.65

180

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.18

10.35

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

304

2.37

10.32

1.6

1.4

28871.9

74131.8

e6/l

0.97

186

(3022313) Gas panel - Capillary blood

200

1227

1.67

10.28

6.2

4.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

175

2.83

10.27

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

299

2.37

10.23

2.4

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

293

2.39

10.21

7.6

3.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.82

10.20

1.3

1.6

—

(3042631) Mycobacterium sp identified in Specimen

345

2.26

10.09

3.0

2.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

4.63

10.00

1.3

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

373

2.20

9.94

1.7

1.5

31.0

31.5

g/l

0.14

341

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1635

14457

1.27

9.93

3.7

2.9

—

(3009871) Measles virus Ab [Titer] in Serum

4.15

9.89

1.5

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

111

578

1.95

9.83

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

238

2.51

9.77

1.1

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

169

2.81

9.75

1.2

1.4

1.9

2.0

mmol/l

1.16

159

(3047007) Chlamydophila sp Ab [Presence] in Serum

314

2.29

9.61

1.2

—

(3011288) Drugs identified in Urine by Screen method

473

2.04

9.55

6.2

2.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

106

550

1.96

9.50

4.2

1.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

123

3.12

9.48

4.1

3.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

3.39

9.17

5.8

4.8

5888.1

75.8

mg/l

0.48

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

100

3.32

9.16

1.8

2.6

55.9

122.2

umol/l

1.81

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2577

24258

1.35

9.16

38.5

15.1

31.9

25.0

mg/l

19.08

2362

19481

(3003181) Sodium [Moles/volume] in Urine

457

2.02

8.96

1.6

1.4

62.1

63.6

mmol/l

0.14

373

(3002523) Influenza virus A Ag [Presence] in Specimen

337

2.19

8.94

1.2

1.1

—

(3013512) EKG study

874

7223

1.29

8.90

6.0

4.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

338

2.19

8.88

1.8

1.4

2805.2

1878.2

e6/l

0.33

245

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

294

2.27

8.81

2.5

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

3.36

8.75

3.8

3.9

52.1

53.9

0.18

(40761536) Microorganisms panel - Urine sediment

299

2089

1.48

8.72

7.1

4.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

174

2.67

8.70

1.5

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

296

2.26

8.68

2.5

1.4

—

(3028433) Virus identified in Specimen by Culture

3.74

8.61

1.4

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

234

1558

1.54

8.59

2.5

2.4

33.4

20.4

au/ml

—

(40761535) Cells panel - Urine sediment

303

2129

1.47

8.59

5.7

3.4

—

(3012441) Differential panel - Pleural fluid

292

2.25

8.52

1.6

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

8.49

8.46

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

180

1131

1.63

8.46

1.5

1.3

—

(3016879) Cocaine [Presence] in Urine

116

645

1.83

8.46

4.3

2.0

—

(3025315) Body weight

7.52

8.41

3.7

4.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.17

8.40

1.4

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.17

8.40

1.4

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.17

8.40

1.4

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

294

2.24

8.39

2.5

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

918

7692

1.27

8.26

5.0

4.0

21.6

11.8

mg/mmol

2.06

649

4948

(3011648) Oxygen content in Venous blood

197

2.51

8.22

3.7

2.6

10.7

11.1

0.29

197

(3035637) Corticotropin [Mass/volume] in Plasma

284

2.24

8.20

1.4

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

337

2.13

8.15

1.2

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

364

2672

1.41

8.14

2.0

1.8

1.6

1.5

2.06

315

2330

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.95

7.87

1.3

1.1

—

(3012565) Volume of 24 hour Urine

111

2.99

7.76

2.8

2.7

1445.6

1915.2

1.20

(3019768) Coxiella burnetii Ab [Presence] in Serum

6.69

7.60

1.0

1.4

—

(3045788) Cell count panel - Pleural fluid

268

2.22

7.57

1.5

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

142

2.70

7.41

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.61

7.29

1.4

1.1

—

(3022621) pH of Urine by Test strip

242

1682

1.48

7.26

3.4

3.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

467

1.89

7.14

1.2

1.0

4.4

u/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.20

6.97

1.6

2.3

—

(3014271) Vancomycin [Susceptibility]

153

2.57

6.93

3.1

—

(3050794) Legionella sp Ab [Presence] in Serum

6.02

6.90

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

6.02

6.90

1.2

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.06

6.88

1.1

1502.5

1585.9

miu/ml

0.13

(40757373) Influenza virus identified in Isolate

3.57

6.86

1.3

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

207

1414

1.50

6.78

1.4

1.3

48.1

54.3

au/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

4.46

6.70

1.6

1.4

—

(3048879) Bone marrow aspiration report

3.22

6.69

3.5

1.7

—

(3027008) Opiates [Presence] in Urine

117

702

1.69

6.64

4.3

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

116

695

1.69

6.62

4.3

2.0

—

(3028300) Cannabinoids [Presence] in Urine

117

705

1.69

6.54

4.3

1.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

489

1.82

6.51

1.7

—

(3037121) Protein [Mass/volume] in Urine

143

908

1.60

6.51

5.2

3.1

0.4

0.3

g/l

0.42

363

(3002256) Pathology report gross observation

406

3142

1.34

6.50

1.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

115

692

1.69

6.46

4.4

1.9

—

(3051651) Icteric interference index of Serum or Plasma

141

2.57

6.44

4.9

3.6

—

(3017704) Immunofixation for Urine

159

2.47

6.43

2.0

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

215

3021

0.69

6.36

4.5

4.4

31.3

32.6

1.07

165

2010

(3032743) Legionella sp IgG Ab [Presence] in Serum

6.68

6.31

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

6.68

6.31

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.59

6.31

1.8

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

102

599

1.73

6.27

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.35

6.27

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.35

6.27

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

264

2.10

6.22

1.9

2.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

203

1408

1.47

6.18

1.6

1.3

363.6

240.1

u/ml

0.68

189

1299

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

115

2.71

6.17

7.4

6.5

39.0

55.5

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

340

1.96

6.16

1.2

1.6

3.9

u/ml

1.44

113

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

610

5021

1.27

6.12

1.3

1.2

2.3

1.6

u/ml

0.42

142

1329

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.81

6.10

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

307

2.01

6.09

1.4

1.6

72.7

63.3

1.33

193

(40768806) Pleura Pathology biopsy report

294

2.03

6.05

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

105

2.78

6.05

1.1

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

583

1.72

6.04

1.3

1.2

35.9

3.7

u/ml

0.63

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

254

2.11

6.03

1.5

1.3

329.8

334.6

u/l

0.02

245

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

100

591

1.71

6.03

1.3

1.2

3.2

9.6

u/ml

1.33

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.94

5.99

1.2

1.1

55.2

552.5

ng/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

470

3768

1.29

5.81

1.7

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

480

3865

1.29

5.73

1.3

32.6

36.1

iu/ml

0.24

151

1215

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

137

889

1.57

5.73

1.1

66.3

1.7

u/ml

—

(3009508) Creatinine [Moles/volume] in Urine

891

7695

1.22

5.72

4.4

3.2

7.0

7.5

mmol/l

2.73

757

6443

(3020191) Ethanol [Moles/volume] in Serum or Plasma

181

2.28

5.71

2.4

1.4

1.5

1.2

promille

0.60

138

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

104

632

1.67

5.68

1.3

1.2

17.2

38.8

u/ml

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

274

2.03

5.67

1.3

1.2

39.9

54.2

u/ml

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

113

703

1.63

5.63

2.3

2.2

4215.9

4370.4

u/l

0.03

286

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

103

627

1.66

5.59

2.9

2.4

175.0

101.9

ug/min

0.73

398

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.29

5.58

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.15

5.46

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.03

5.37

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

505

1.72

5.34

3.1

1.8

1.0

0.8

nmol/l

0.91

419

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

233

2.08

5.32

1.7

1.4

24.2

27.4

0.24

140

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

11.28

5.29

2.1

3.3

—

(3044007) Cell count panel - Peritoneal fluid

3.06

5.21

3.1

2.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

202

2.14

5.19

1.4

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2109

19816

1.20

5.14

39.6

18.2

14.3

13.8

36.04

2076

19358

(3003338) MCHC [Mass/volume]

2150

20237

1.20

5.14

41.5

19.4

330.4

332.2

g/l

14.80

2126

20039

(3019832) Treponema pallidum Ab [Presence] in Serum

254

1903

1.36

5.05

1.9

1.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.57

5.04

1.9

1.5

6.1

6.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

330

1.87

5.00

1.3

1.2

2.8

5.3

u/ml

1.32

146

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2280

23912

0.83

4.97

5.2

4.9

2.6

2.7

mmol/l

6.23

2117

21879

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

123

2.45

4.95

1.6

1.5

—

(3036782) Glucose [Moles/volume] in Pleural fluid

275

1.94

4.92

1.7

1.4

6.2

6.7

mmol/l

0.54

256

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

151

1036

1.48

4.92

6.8

4.5

24.4

24.8

mmol/l

1.20

143

954

(3019977) pH of Arterial blood

142

2.34

4.91

1.8

2.8

7.4

0.22

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.67

4.91

1.8

1.5

2.3

2.4

0.01

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.08

4.89

1.2

—

(3044927) Protein electrophoresis panel - Urine

284

1.92

4.83

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.30

4.82

1.5

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.01

4.77

1.1

1.2

—

(3022145) Colonoscopy Study observation

329

2585

1.30

4.73

1.5

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.80

4.71

1.1

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

648

5522

1.22

4.63

1.9

1.7

10450874.5

27521756.4

pmol/l

0.76

555

4571

(3035880) pH of Pleural fluid

159

2.21

4.62

1.7

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

192

2.10

4.61

1.5

1.3

23.4

14.0

u/l

0.79

180

(40768441) Liver Pathology biopsy report

166

2.18

4.59

2.4

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

459

1.69

4.58

1.2

51.4

40.8

u/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

190

1383

1.40

4.53

3.2

3.3

4.3

4.5

pmol/l

2.04

165

1209

(4198724)

2.73

4.51

3.3

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

435

5261

0.80

4.48

2.7

3.1

0.8

ug/l

0.17

308

3553

(21494755) Public health laboratory ask at order entry panel

132

1896

0.68

4.44

1.4

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

619

1.59

4.43

1.3

204.2

221.3

miu/ml

0.17

272

(3027456) Digoxin [Moles/volume] in Serum or Plasma

596

1.60

4.41

3.5

3.1

0.9

0.8

nmol/l

0.55

456

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.01

4.39

1.2

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.63

4.39

3.7

2.5

437.6

760.9

e6/l

0.88

(3009542) Hematocrit [Volume Fraction] of Blood

2296

21852

1.19

4.37

34.4

16.0

37.4

39.4

14.58

1555

15169

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.10

4.36

14.5

8.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.74

4.34

3.5

2.3

8268.0

24493.6

e6/l

0.33

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

129

1851

0.68

4.32

1.6

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

594

1.58

4.25

3.0

2.2

—

(3012516) Albumin [Mass/volume] in Urine

831

7301

1.19

4.24

4.2

3.3

687.7

299.0

mg/l

1.28

587

4735

(40768797) Stomach Pathology biopsy report

405

3312

1.26

4.24

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

448

3708

1.24

4.21

1.3

1.2

10.6

12.6

u/ml

0.24

164

1432

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.75

4.18

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

214

1.98

4.16

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

235

1.93

4.15

1.6

1.3

193744.8

90664.4

e6/l

0.26

162

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

160

2.14

4.15

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.36

4.09

2.8

2.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

368

1.73

4.07

1.5

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

168

2.10

4.07

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

168

2.10

4.07

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

168

2.10

4.07

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

162

2.11

4.03

1.2

—

(4268621)

224

1.93

4.01

2.2

2.3

—

(3013862) HLA-DP [Type]

10.02

4.01

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.68

3.99

1.0

1.1

—

(3016038) Potassium [Moles/volume] in Urine

163

2.10

3.97

1.7

1.2

35.4

35.0

mmol/l

0.03

149

(3020891) Body temperature

149

1068

1.41

3.92

8.6

4.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

171

2.06

3.90

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

171

2.06

3.90

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

171

2.06

3.90

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.89

3.89

4.8

2.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2221

23201

0.85

3.86

4.8

4.3

1.4

mmol/l

15.93

2068

21206

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.29

3.86

4.6

3.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1244

0.64

3.83

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2242

23396

0.85

3.81

4.9

4.4

4.6

mmol/l

9.73

2090

21540

(3007463) Buprenorphine [Presence] in Urine

8.77

3.77

3.7

2.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

8.77

3.77

2.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

178

1325

1.36

3.75

2.6

2.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2225

23221

0.86

3.73

5.2

4.6

6.2

6.0

mmol/l

5.32

2039

20979

(3033799) Differential panel - Peritoneal fluid

2.65

3.73

3.1

2.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

341

1.71

3.70

1.1

—

10.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.01

3.70

1.2

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

2.80

3.68

1.6

1.9

—

(36660697) Celiac disease serology panel - Serum

228

1767

1.31

3.67

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

253

1.83

3.67

2.5

2.1

8.4

8.3

umol/l

0.02

177

(3043409) Potassium [Moles/volume] in Arterial blood

117

813

1.46

3.66

8.0

3.9

4.0

3.9

mmol/l

1.36

109

755

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.70

3.65

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

254

1.82

3.63

4.6

3.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.44

3.61

1.1

93.6

95.5

0.08

(3019150) Specific gravity of Urine by Refractometry

612

5307

1.19

3.58

6.1

4.2

1.0

kg/l

0.41

107

782

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.95

3.57

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

300

1.75

3.55

1.7

1.3

—

(21494434) Karyotype in Bone marrow

249

1.82

3.53

1.1

1.2

—

(3024263) Appearance of Synovial fluid

138

2.11

3.49

1.9

1.6

—

(3002619) Bacteria identified in Specimen by Culture

2.99

3.41

1.1

—

(3042517) Benzodiazepines panel - Urine

5.01

3.37

1.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

328

1.69

3.36

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

645

7326

0.85

3.36

3.8

4.4

23.6

21.9

1.73

325

3637

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

189

1.92

3.33

1.2

1.3

13.3

12.4

mmol/l

0.19

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.37

3.31

1.0

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

218

1.85

3.31

1.1

1.0

—

(3011985) Renin [Units/volume] in Plasma

285

1.73

3.28

1.4

1.3

47.0

67.0

mu/l

0.72

249

(40763590) HLA-DQ beta [Type]

8.58

3.26

1.0

—

(46236302) HLA-C [Type] by High resolution typing

8.58

3.26

1.0

—

(40760409) HLA-A [Type] by High resolution

8.58

3.26

1.0

—

(40760410) HLA-B [Type] by High resolution

8.58

3.26

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

8.58

3.26

1.3

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.17

3.21

1.7

1.1

0.7

1.2

mmol/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

172

1.93

3.14

3.6

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

527

1.51

3.07

4.6

3.3

100.6

882.7

u/ml

0.95

487

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.24

3.05

1.1

—

(40768443) Skin Pathology biopsy report

139

1033

1.36

3.02

1.3

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

133

2.04

3.01

1.8

1.4

1.0

1.2

nmol/l

0.28

102

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

10.01

2.98

1.0

—

(3039000) Anion gap in Blood

564

1.48

2.97

8.3

7.1

11.7

11.3

mmol/l

0.58

500

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

107

2.16

2.96

1.0

1.2

—

(3018572) Chloride [Moles/volume] in Blood

565

1.48

2.94

8.3

7.0

104.3

105.2

mmol/l

0.93

501

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.15

2.93

1.0

1.1

—

(4281824)

228

1.76

2.91

1.5

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

135

2.01

2.90

1.6

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

135

2.01

2.90

1.6

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

2.59

2.87

2.3

2.1

158.9

251.0

e6/l

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.26

2.86

1.6

1.3

3.5

3.4

mmol/l

0.03

(3000012) Reticulocyte production index

129

2.02

2.85

2.5

1.7

—

(3044889) 12 lead EKG panel

1787

16932

1.13

2.84

4.9

3.9

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.65

2.79

1.6

2.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.47

2.78

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.23

2.77

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.17

2.76

2.1

1.8

—

(3016135) IgD [Mass/volume] in Serum

8.34

2.75

1.4

1.3

41.5

131.9

mg/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.32

2.74

1.1

1.2

33.2

38.6

g/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

181

1.83

2.73

1.3

1.5

23.7

22.3

u/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

5.01

2.72

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.72

2.71

18.0

8.3

—

(3049717) Cytology report of Urine Cyto stain

138

1045

1.34

2.69

2.5

2.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.76

2.67

1.2

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

119

2.02

2.66

1.5

1.3

5.7

5.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

455

1.51

2.65

1.2

121.1

40.3

u/l

1.53

392

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.13

2.64

1.1

1.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2566

24937

1.16

2.62

38.7

17.6

139.1

139.6

mmol/l

14.81

2504

24275

(3052592) Norovirus Ag [Presence] in Stool

2.55

2.61

1.9

1.3

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.67

2.59

1.0

1.1

20.2

21.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.67

2.59

1.0

1.1

7.3

8.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

4.67

2.59

1.0

1.1

38.1

37.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2160

22403

0.88

2.57

4.5

3.9

1.4

1.3

mmol/l

8.11

2005

20344

(3036603) Volume of Urine

156

1.87

2.56

1.6

1.4

1426.6

1878.9

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.15

2.55

1.0

1.3

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

2.8

3.4

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.15

2.55

2.8

3.4

—

(3013762) Body weight Measured

5.46

2.54

1.0

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.46

2.54

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.23

2.53

2.0

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.23

2.53

2.0

2.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

172

1.81

2.50

2.9

1.7

—

(40768804) Tissue Pathology biopsy report

1046

9654

1.13

2.49

2.3

2.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2569

24993

1.15

2.48

39.2

17.7

4.0

mmol/l

0.20

2504

24294

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

294

1.61

2.48

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

271

1.63

2.47

1.2

1.3

304.2

290.9

pmol/l

0.07

204

(3025018) Bordetella pertussis Ab [Titer] in Serum

123

1.96

2.45

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.56

2.44

1.8

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.24

2.44

3.2

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

155

1214

1.29

2.40

1.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

273

1.62

2.40

1.3

—

nmol/l

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.12

2.36

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

238

1.65

2.28

2.4

2.0

1.6

2.0

u/field

0.13

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.23

2.27

1.1

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

5.56

2.21

4.4

5.0

339.0

409.6

umol/l

—

(3009677) Dengue virus Ab [Presence] in Serum

5.56

2.21

1.0

—

(3008295) Osmolality of Serum or Plasma

264

1.60

2.20

1.2

1.4

280.1

279.7

mosm/kgh2o

0.03

194

(3045414) Leukocytes [Presence] in Urine

143

1123

1.29

2.20

2.7

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

180

1.73

2.18

1.2

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

129

1.87

2.16

14.3

13.8

891.3

815.7

nmol/l

0.35

123

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

4.29

2.15

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.29

2.15

1.2

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.69

2.15

1.3

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1897

18190

1.11

2.12

4.3

3.9

14.7

14.9

pmol/l

2.70

1757

16434

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

145

1.80

2.10

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

118

910

1.31

2.09

1.5

1.4

24.7

26.2

iu/l

0.20

107

770

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

138

1.82

2.09

1.0

1.1

12.3

12.8

iu/ml

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

229

1.62

2.08

1.2

1.3

1.7

1.4

nmol/l

0.65

204

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.91

2.07

1.3

1.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

2.33

2.04

2.1

3.5

—

111.6

au/ml

—

(3034426) Prothrombin time (PT)

2.18

2.04

1.1

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

118

1.87

2.01

12.5

14.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.01

2.00

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.82

2.00

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.15

1.98

1.6

1.3

6.8

101.4

ug/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.75

1.93

1.3

1.6

—

(3025130) Human papilloma virus identified in Specimen

258

1.56

1.92

2.2

1.8

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.06

1.90

3.8

1.7

2.2

2.0

umol/l

0.35

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.17

1.82

34.8

10.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

176

1452

1.22

1.82

1.3

1.2

117.4

140.2

iu/ml

0.33

533

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.76

1.79

1.4

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

232

1970

1.19

1.78

1.5

1.4

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

161

1.68

1.78

2.8

1.5

0.9

1.0

g/l

0.65

161

(3017569) Oxygen content in Arterial blood

124

1.78

1.75

1.4

2.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.74

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.50

1.74

2.0

1.6

145.5

145.3

ng/l

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

550

1.35

1.73

2.1

1.9

3.6

4.6

iu/l

0.62

188

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

372

1.43

1.73

1.1

11.7

1596.9

iu/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

271

3127

0.85

1.73

15.4

7.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.92

1.72

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.30

1.70

1.5

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

621

0.69

1.67

1.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

276

1.49

1.66

1.2

1.4

28.4

24.0

u/l

0.32

223

(44816559) Phosphatidylethanol [Mass/volume] in Blood

427

1.39

1.64

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

127

1.74

1.64

1.3

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.58

1.61

1.0

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

601

1.32

1.61

1.4

11.2

9.1

u/l

0.67

485

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.50

1.59

1.3

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.91

1.59

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.00

1.58

1.2

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.70

1.58

1.4

2.1

—

(40768800) Prostate Pathology biopsy report

554

0.68

1.57

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

117

941

1.25

1.56

1.8

—

(3006653) Thiamine [Moles/volume] in Blood

122

1.73

1.54

1.1

1.2

137.1

139.2

nmol/l

0.06

122

(3029075) Extractable nuclear Ab panel - Serum

1.98

1.53

1.1

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.28

1.53

1.2

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.34

1.52

8.4

5.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.60

1.51

3.6

1.2

—

652.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.60

1.51

1.1

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.60

1.51

10.6

4.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

381

0.63

1.49

1.7

—

(37021550) Renin [Units/volume] in Plasma --upright

2.07

1.49

1.3

118.6

71.8

mu/l

0.28

(3024869) Neuronal Ab [Presence] in Serum

2.37

1.45

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.37

1.45

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

172

1.57

1.43

1.3

1.1

—

4.4

—

(3038026) Centromere Ab [Units/volume] in Serum

190

1.53

1.37

1.2

1.1

—

66.6

—

(3003694) ABO and Rh group [Type] in Blood

706

6570

1.10

1.36

1.5

1.4

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.61

1.36

1.0

1.4

1.9

0.9

ml/s/173m2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

430

0.67

1.34

1.6

1.5

—

(40762814) Titanium [Mass/volume] in Blood

0.00

1.34

0.0

2.2

—

3.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

128

1.64

1.33

1.2

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

704

6565

1.09

1.30

6.7

4.1

0.0

estimate

1.28

276

2176

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.0

1.1

—

(4306422)

326

1.39

1.30

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.36

1.29

1.1

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

122

1.64

1.27

1.2

222.3

357.4

u/l

0.55

109

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.40

1.24

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

1.77

1.23

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

330

1.37

1.22

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

108

1.67

1.22

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.31

1.18

6.2

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

452

0.70

1.17

1.6

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.50

1.15

1.6

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

233

1.42

1.13

1.6

1.5

—

(44806420)

1.71

1.11

1.9

2.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.96

1.11

1.7

1.3

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.96

1.11

2.3

2.0

1.2

mmol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.26

1.10

1.1

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.38

1.09

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

316

0.66

1.09

1.1

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

329

1.34

1.08

1.2

1.1

1.7

1.5

g/l

1.73

300

(3017732) Neutrophils [#/volume] in Blood

186

1630

1.15

1.06

3.4

3.2

4.4

4.1

e9/l

0.60

140

1254

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.12

1.05

2.1

1.5

43.9

47.1

umol/l

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

245

1.39

1.05

1.1

103.9

95.2

0.84

232

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

129

1.55

1.05

2.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.96

1.03

1.7

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

343

1.32

0.99

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

131

1.53

0.99

1.2

1.1

1.0

1.2

u/l

—

(4010399)

193

1706

1.14

0.99

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.95

0.97

1.3

1.4

—

(4027681)

132

1.52

0.97

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

873

9162

0.93

0.96

4.7

5.0

3.8

3.6

ug/l

0.05

777

8142

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

303

1.32

0.93

1.3

1.5

0.2

0.3

nmol/l

1.87

245

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.07

0.89

1.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

160

1.44

0.88

1.1

1.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

127

1.50

0.88

13.3

11.4

0.7

0.6

mmol/l

0.60

117

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

836

0.82

0.87

2.0

1.7

12.1

3.6

mg/l

1.36

594

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.86

0.87

2.3

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.86

0.87

4.5

6.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.86

0.87

1.5

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.00

0.87

9.0

10.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

247

1.34

0.85

1.3

1.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.94

0.84

3.7

2.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.59

0.84

3.7

2.6

29.8

29.6

umol/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

162

1.42

0.84

1.0

825.0

667.2

ng/l

0.65

100

(3010813) Leukocytes [#/volume] in Blood

2644

26747

0.93

0.83

48.8

22.1

7.3

6.9

e9/l

7.59

2583

25929

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

226

2494

0.90

0.83

1.6

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

291

3170

0.91

0.83

1.5

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.74

0.82

3.9

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

172

1.40

0.80

1.6

1.3

4.4

1.4

u/ml

0.69

(3026361) Erythrocytes [#/volume] in Blood

2644

26738

0.93

0.79

48.6

22.0

4.3

4.5

e12/l

46.24

2578

25922

(3000963) Hemoglobin [Mass/volume] in Blood

2645

26746

0.93

0.79

49.0

22.2

127.9

134.5

g/l

74.88

2603

26295

(3035941) MCH [Entitic mass]

2644

26736

0.93

0.78

48.4

21.9

30.2

30.3

5.30

2602

26279

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.67

0.78

1.0

1.1

—

5.8

—

(4034850)

814

0.83

0.78

15.8

10.4

—

(3024731) MCV [Entitic volume]

2644

26735

0.93

0.78

48.5

22.0

91.2

0.13

2603

26283

(3007461) Platelets [#/volume] in Blood

2643

26722

0.93

0.77

48.7

22.0

247.5

247.1

e9/l

0.09

2581

25992

(3020491) Glucose [Moles/volume] in Blood

191

1.36

0.77

1.5

2.0

7.3

7.0

mmol/l

0.15

126

(3021387) Prolactin [Units/volume] in Serum or Plasma

751

1.18

0.76

1.7

1.6

330.9

306.2

mu/l

0.28

679

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

887

0.84

0.76

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

223

2030

1.11

0.74

2.1

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

245

2242

1.10

0.74

2.2

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.84

0.73

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.00

0.72

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.00

0.72

1.4

1.5

—

(4015189)

1.62

0.71

1.5

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

282

1.28

0.71

1.4

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

309

1.27

0.70

1.1

1.7

2.4

u/ml

0.41

127

(3044242) Glucose [Moles/volume] in Arterial blood

143

1.40

0.70

1.3

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

129

1143

1.13

0.70

1.1

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

1.64

0.68

1.8

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.68

1.1

2.3

16.6

17.4

umol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.67

0.68

2.4

3.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

127

1.42

0.68

1.0

1.1

1.0

ratio

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

102

1.47

0.67

1.2

—

(1761868) Lipid panel - Serum or Plasma

762

7933

0.95

0.64

3.4

2.9

—

(4094501)

623

0.83

0.64

1.2

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.59

0.61

2.2

1.3

23.0

23.6

—

(3015183) Erythrocyte sedimentation rate

113

1.42

0.61

1.1

1.2

—

(3019225) pH of Specimen

272

2534

1.08

0.58

9.1

4.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.58

0.0

1.1

—

11.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.72

0.57

1.8

1.2

298.8

122.2

ng/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1070

0.88

0.55

1.9

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2279

22500

1.05

0.55

30.3

14.1

76.1

78.9

ml/min/173m2

5.62

2049

18583

(3008898) HLA-B27 [Presence]

730

1.14

0.54

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

117

1.37

0.52

3.5

1.8

—

(3000285) Sodium [Moles/volume] in Blood

1.50

0.51

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

379

1.19

0.51

1.8

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

848

1.12

0.50

1.8

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

234

1.24

0.49

2.0

1.5

2.2

3.4

ug/l

0.92

208

(40768793) Breast Pathology biopsy report

468

1.16

0.45

1.2

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2182

22070

0.96

0.44

7.3

5.9

41.7

40.2

mmol/mol

7.84

2034

20301

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

121

1.32

0.44

1.3

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

588

6095

0.96

0.44

1.8

1.6

1.5

1.4

mmol/l

2.67

516

5119

(40761511) CBC panel - Blood by Automated count

2485

25063

0.96

0.42

30.9

14.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.65

0.42

1.2

1.5

—

(3045716) Anion gap in Serum or Plasma

131

1.30

0.42

2.8

1.8

10.2

9.7

mmol/l

—

104

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.0

—

(4024509)

235

0.81

0.37

1.4

1.6

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.36

0.34

1.0

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2215

21947

1.03

0.33

5.3

4.7

3.2

2.1

mu/l

0.45

2080

19965

(3014133) Dog dander IgE Ab [Units/volume] in Serum

275

0.84

0.33

1.1

2.6

3.5

u/ml

0.31

106

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

616

1.11

0.32

1.2

1.1

7.0

5.9

u/ml

0.11

(1617658) Protocol used for examination of sentinel lymph nodes

164

1.22

0.32

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.28

0.32

2.7

6.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

781

1.09

0.31

1.6

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

504

0.89

0.29

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

345

0.87

0.29

1.0

1.1

0.7

1.4

u/ml

0.65

153

(3047352) Trisomy 18 risk [Likelihood] in Fetus

376

0.88

0.28

1.6

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

112

1.25

0.28

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

563

0.90

0.27

1.6

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

141

1.21

0.26

2.4

2.1

278.0

138.4

ug/min

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.25

0.25

1.1

1.3

7.7

9.0

ug/l

—

(3000034) Microalbumin [Mass/volume] in Urine

217

1.15

0.24

3.1

3.2

231.6

30.7

mg/l

0.72

166

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.27

0.24

4.3

2.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.32

0.23

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.77

0.22

1.7

2.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

399

0.90

0.22

1.0

1.1

2.0

1.7

u/ml

0.10

170

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

449

1.09

0.21

1.7

1.5

311.1

195.3

pmol/l

0.25

442

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

13.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

105

0.76

0.21

1.4

1.5

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

459

0.91

0.20

1.5

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

0.80

0.20

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

155

1.16

0.19

1.7

1.9

—

(44813793)

137

1.17

0.18

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.13

0.18

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

384

0.91

0.18

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

373

0.91

0.18

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2562

25522

1.02

0.16

19.8

10.3

27.2

26.1

u/l

0.50

2507

24546

(4146454)

267

0.90

0.16

3.0

2.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

462

0.93

0.15

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

461

0.93

0.14

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

460

0.93

0.14

1.5

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

189

1.11

0.13

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

355

0.93

0.12

1.0

1.1

7.6

5.5

u/ml

0.29

184

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

143

1.12

0.11

2.4

1.7

3.6

2.4

u/field

0.19

106

(3000492) Spirometry study

223

2185

1.02

0.10

1.6

1.5

—

(1002224) Polysomnography panel

871

1.03

0.09

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

291

1.07

0.09

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.09

0.09

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

165

1.09

0.08

1.4

63.6

57.6

pmol/l

—

(3006462) Nitrate [Presence] in Urine

113

0.88

0.08

2.1

3.4

—

(3013637) Mi-2 Ab [Presence] in Serum

0.83

0.08

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.83

0.08

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.83

0.08

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.83

0.08

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.06

0.08

2.1

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.08

0.07

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.86

0.07

1.3

32.5

34.0

nmol/l

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.03

0.07

3.4

2.1

15.3

110.8

ug/l

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

224

0.94

0.06

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

111

0.90

0.06

1.0

1.1

0.6

22.5

u/ml

—

(3045424) Erythrocytes [Presence] in Urine

416

0.96

0.06

2.1

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

334

0.96

0.05

1.1

1.5

2.3

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

653

1.03

0.05

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

181

1834

0.99

0.05

2.4

2.2

12.0

12.5

nmol/l

0.34

157

1605

(3045683) HLA typing for celiac disease panel - Blood or Tissue

120

1.08

0.04

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

250

0.96

0.03

1.1

4.1

5.1

u/ml

0.17

103

(3051387) C reactive protein [Mass/volume] in Capillary blood

592

0.98

0.03

6.6

3.7

33.5

27.7

mg/l

0.65

386

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

290

0.97

0.03

1.3

7.7

7.4

mmol/l

0.15

211

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

132

1.06

0.02

4.2

6.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

201

0.99

0.00

1.2

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

136

1.03

0.00

1.6

1.7

6.6

7.8

mmol/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

122

0.98

0.00

1.2

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

152

1522

1.00

0.00

1.2

—

(4211845)

123

0.98

0.00

2.3

3.3

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

2.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.91

0.00

1.0

—

(3020650) Glucose [Presence] in Urine

0.91

0.00

1.2

1.6

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.88

0.00

1.8

1.5

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.6

—

2984.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

9.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_OTHER_INFECTIONS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_OTHER_INFECTIONS	2.899 [2.57, 3.27]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.203

During the follow-up period (1.1.1998 — 31.12.2019), 5152 out of 11728 females with AB1_OTHER_INFECTIONS died.

Males

Parameter	HR [95% CI]	p-value
AB1_OTHER_INFECTIONS	3.052 [2.66, 3.49]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 5986 out of 12760 males with AB1_OTHER_INFECTIONS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_OTHER_INFECTIONS.

N-year risk	Females	Males
1	0.244%	0.699%
5	1.528%	3.358%
10	4.186%	7.93%
15	8.183%	15.529%
20	14.109%	25.974%

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_INFECTIONS – Other infectious diseases

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other infectious diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints